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ABSTRACT

KETOMETHYLENE ISOSTERIC AMIDE BOND REPLACEMENTS VIA THE ZINCMEDIATED CHAIN EXTENSION OF N-PROTECTED AMINO ACIDS
by
Cory Theberge
University o f New Hampshire, May, 2002

A methodology for the chain extension of N-protected amino acid P-keto esters to
y-keto esters utilizing a zinc carbenoid was developed. The reaction was used on amino
acids containing various protective groups and a variety o f side chain functionality. This
method was used in the incorporation of ketomethylene isosteric amino acid
replacements within amino acid sequences. The usefulness o f the method on molecules
supported by a solid phase was explored.

xv
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INTRODUCTION

Chain Extension Chem istry
The production o f y-keto esters has typically been a challenge to chemists.
Generation o f y-keto esters has been accomplished via reactions in which separate
sources o f ketone and ester functionality are brought together, although these routes are
often difficult to perform on complex starting materials. 1 Other approaches to y-keto
esters involve the intermediacy o f a cyclopropyl alkoxide, including the work of
Bieragel, 2 Reissig, 3 Saigo, 4 and Dowd. 5 The zinc-mediated chain extension reaction6 was
first demonstrated in the conversion o f p-keto esters (1) to y-keto esters (3) and most
likely involves the cyclopropyl alcohol intermediate 2. This procedure is the mildest and
most rapid method o f formation o f y-keto esters reported thus far.

X
O

R'
1

P-keto ester

R'

new carbon

2

3
y-keto ester

Scheme 1. The Zinc-Mediated Chain Extension Reaction
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Bieraugels’s M ethod
The first approach to a y-keto ester which utilized fragmentation o f an
intermediate cyclopropyl alkoxide equivalent was reported by Bieraugel2 (Scheme 2).
The enamine ester 4 was prepared from a P-keto ester and reacted with a zinc carbenoid
prepared according to the method o f Sawada and Inouye. 7 The 2-aminocyclopropane
ester 5 and the ring opened species 6 were believed to be intermediates in the reaction
which yielded a y-keto ester in very low yield after hydrolysis.

NRa O

EtZnI

R ,N

CH 2 I2

9

nr2 h

H+

H

4

Scheme 2. Bieraugel’s Cyclopropanation Method

Saieo’s M ethod
Saigo4 modified Bieraugel’s method by forming the TMS enol ether 7 from a Pketo ester and exposing it to Simmons-Smith cyclopropanation conditions (Scheme 3).
O
™SO
O
Zn/Cu
}A ^ A n o .
R' ^
'O r ,CH2 I2
7

TMSO

O

R'

O

D/ ^VV//\ / ^ sQU
a.) KOH/CH3 OH
b.) H 3 0 +

9

O

+
OH

8
10
Scheme 3. Saigo’s Cyclopropanation Method

The TMS-protected cyclopropyl alcohol intermediate 8 was anticipated, but
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saponification o f the product mixture revealed the formation o f the carboxylic acids 9 and
10, arising from multiple addition o f the carbenoid. Even though yields were favorable,
none of the desired y-keto products were formed.

Reissig’s M ethod
Reissig and coworkers3 developed a complementary chain extension reaction
(Scheme 4) in which the ester was introduced via a [2+l]-cycloaddition o f
(methoxycarbonyl)-carbenoid derived from methyl diazoacetate to a silyl enol ether 1 1 .
This route differs from Bieraugel’s and Saigo’s in its disconnection o f the desired
cyclopropyl intermediate 12. The cyclopropyl ether 12 was fragmented by treatment with
aqueous acid or fluoride to yield the y-keto ester. The “vicinally donor-acceptorsubstituted” 8 cyclopropane

12

has been demonstrated to be a powerful building block

X y
TMSO

j

F ' or

N,

Cu(acac) 2

R

R"CHO^

u
a: X= C 0 2 R', Y = H
b: X= H, Y = COiR'

T iC l4

or"Yoh
.A jy O R *
13

O

Scheme 4. Reissig’s Cyclopropanation Method

in organic synthesis. Interestingly, simultaneous fragmentation of the cyclopropane and
formation o f a new carbon-carbon bond through treatment with an aldehyde and TiCU
was shown to stereoselectively yield anti a-substituted y-keto esters 13.9

3
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Dowd’s Method
A chain extension reaction developed by Dowd and coworkerss utilizes a
radical-mediated reaction to form y-keto esters (Scheme 5). Treatment o f an exsubstituted P-keto ester with a

O

O
J[

][

R

7

C

1 ,1

-dibromoalkane yielded the halide 14. Exposure to

nBu3SnH
0R" " A r o iT

(O

o) O

O

R 'W ^ O R "
R'

14

16

15
0

R'

. nBujSnH

O

R*
OR"

OR'

18

17

0

Scheme 5. Dowd’s Cyclopropanation Method

tri-n-butyl tin hydride and an initiator provided the primary radical 15, which added into
the adjacent ketone carbonyl to give the cyclopropyl radical 16. Fragmentation to the
ester-stabilized radical 17 and subsequent abstraction o f a hydrogen atom from tri-n-butyl
tin hydride yielded an a-substituted y-keto ester 18. While Dowd’s method proved to be
useful in the synthesis o f a variety o f substituted P-keto esters, it could not be applied to
a-unsubstituted (R’ = H) substrates, which are readily transformed to side products via
elimination o f the halide in 14. Dowd’s method is nicely complementary to the zincmediated approach described below, which works poorly with a-substituted P-keto esters.

4
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Zercher’s Method
The most recent chain extension methodology developed by Zercher and
coworkers utilizes Furakawa-modified Simmons-Smith cyclopropanation conditions. 10
This one-pot procedure involves the exposure of an a-unsubstituted pketo ester 1 to a zinc carbenoid, forming the proposed cyclopropyl alcohol
X

X
I
Zn.

Et2Zn
R T
R'

O

OR"CH2l2,Ocq
R

Y

O
O

^

'O R ’

R’
OR"

aq. NH4 CI

R'

20a R"' = ZnX
b Rm= H, R' = H

19
O

0R-

L R"

R'

1

i
^Zn..,

O

0

X
1
.Zn.

ZnX
OR"

O'

J

R'

22

*0

21

ORt

"

Scheme 6 . Mechanism of Zercher’s Zinc-Mediated Chain Extension Reaction

intermediate 2 (Scheme 1). Treatment with mild aqueous acid thus affords the y-keto
ester 3 in a straightforward manner.
The proposed mechanism of the chain extension reaction (Scheme 5), based on
analogy to the earlier work o f Bieraugel, 2 Saigo, 3 Reissig, 4 Dowd, 5 and on work done in
the Zercher research group, 1 1 , 1 2 ,1 3 involves initial deprotonation o f the p-keto substrate 1
by diethyl zinc or the zinc carbenoid to form the zinc enolate 19. Formation of the
enolate 19 has been

confirmed by its NMR chemical shifts and the presence of

solubilized ethane gas, a byproduct o f enolate formation. 12 Direct alkylation o f the zinc

5
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enolate 19 with ethyl(iodomethyl)zinc gives the organometallic intermediate 20 which
reacts with the adjacent ketone carbonyl to provide the zinc cyclopropyl alkoxide 2 .
Evidence for the presence o f 20a as an intermediate has been shown through the isolation
of a-methylated material

20

equivalents of diethyl zinc.

b after the reaction is performed with less than three
This result is presumed to be due to the lack of zinc

counterion stabilization (as in 19) o f the P-keto ester during the reaction . 14 Further
evidence was shown for the existence o f zinc anion

20

a when side products were

observed to be the result o f attack o f 2 0 a at the ketone functionality o f the y-keto ester
products 3 . 15 The zinc cyclopropyl alkoxide intermediate 2 has not been observed during
NMR studies, 12 presumably due to its rapid fragmentation to the carbon-bound zinc
intermediate 22. This intermediate is comparable to the dimeric zinc ester enolates found
in the Reformatsky reaction . 16 Upon addition o f aqueous acid to 22, the a-unsubstituted
y-keto ester 3 is produced.

Scone of the Zinc-M ediated Chain Extension Reaction
In order to demonstrate the utility o f the zinc-mediated chain extension reaction, a
variety o f simple P-keto esters 23 were transformed to the corresponding y-keto ester
products 24 (Table l ) . 6 Alkyl functionality at the a-position o f P-keto esters (R’ * H,
entry i) has led to poor yields and numerous side products, yet cyclopropanation of olefin
functionality (entries g and h) was demonstrated to be slower than chain extension. The
exact reasons for the inefficiency o f the reaction was unknown, although a rationale based
upon stability o f the cyclopropyl alkoxide 2 was initially proposed. Specifically, it was

6
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considered that a-substitution would destabilize the cyclopropane and induce

R*
1

entry
a
b
c
d
e
f
8
h
i

R
ch3
ch3
CH(CH3 ) 2
C(CH3) 3
Ph
CH2 CH2Ph
CH2 CH2 CH=CH2
CH=CHPh
ch3

O

3

R*
H
H
H
H
H
H
H
H
ch3

R”
ch3
C(CH3) 3
c h 2c h 3
ch3
c h 2c h 3
c h 2c h 3
ch3
ch3
ch3

•/•yield 3
81
72
71
70
75
75
74
68

23

Table 1. Zinc-Mediated Chain Extension o f (3-Keto Esters

fragmentation to the isomeric, and much more nucleophilic, ester enolate 21. Studies to
modify the reaction conditions identified that a short reaction time ( 2 min) was sufficient
for minimization o f side products. 17 The instability of the cyclopropyl alkoxide has been
discounted as a significant factor in the efficiency o f a-substituted chain extension
reactions however, since NMR studies have shown that the cyclopropane intermediate
opens quickly in unsubstituted cases as well. It is more likely that the instability o f the
dimeric species 2 2 plays a role in the lack or reactivity o f a-substituted substrates.
An exploration into the chain extension o f simple P-keto phosphonates11 was also
undertaken to probe its applicability in the preparation o f the compounds in Table 2. The

7
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P-keto phosphonates 23 reacted with the zinc carbenoid more slowly than the amide or
ester reactions, although the typical yield of the chain-extended products 24 was not

?

9

«V°^

Et2 Zn/CH2 I2

9

F

R’

O

23

entry
a
b
c
d
e
f
e
h

R
OC(CH3) 3
o c h 2c h 3
ch3
ch3
Ph
ch3
-(CH2)3c h 2 c h 2c h = c h 2

24

R*
H
H
H
H
H
CH3
H

R”
c h 2c f 3
c h 2c h 3
ch3
c h 2c h 3
c h 2c h 3
c h 2c h 3
c h 2c h 3
ch3

% yield 24
NR
NR
85
69
98
70
82
75

Table 2. Zinc-Mediated Chain Extension o f P-Keto Phosphonates

diminished. The p-keto phosphonoacetates (entries a and b) proved to be unreactive. The
presence o f a-substitution (R’ in entry f) provided no barrier to efficient reaction,
although starting materials which contained alkenes(entry h) resulted in the generation of
cyclopropanated species as unavoidable minor products. Formation of the P-keto
phosphonate from N-Boc-alanine 25 (Scheme 7) involved the straight-forward
application o f Koskinen’s method. 18 The amino acid-derived substrates 27 reacted well
under the chain extension conditions. The observation that the chain extension reaction
proceeded efficiently in the presence o f Lewis basic functionality like carbamates

8
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CH,
CH3
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CH2 C12

ch

27

3
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28

Scheme 7. Formation of y-Keto Phosphonate Amino Acid Derivatives

indicated that this method might be applicable to more complex peptidyl systems. The
successful application o f the chain extension reaction to 27 indicated that the presence of
the modestly acidic N-H did not deter the zinc-mediated transformation.

X

I 19

entry
a
b
c
d
e
f

e
h
i
i

k

B jf r 'C H A
CHjClj

X ^

I

R

30 °

*

R

R’

R”

% yield 30

ch 3
ch 3
ch 3
ch 3
ch 3
ch 3
ch 3
ch 3

ch 3

ch3

60
33
88
70
10
81
47
55
42
60
59

Ph
t-Bu
Ph

Ph
H
ch 3
Ph
n -C ^
n-C*H9
H
H
H
n-CeHi 1
*(CH2)4H
CH2 C H C H 2
Bn
Bn
Bn
Bn
ch 3

ch 3

Table 3. Zinc-Mediated Chain Extension of (3-Keto Amides

9

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

The conversion o f p-keto amides to y-keto amides (Table 3) was also explored.
When p-keto amides 29 were subjected to the same conditions as P-keto esters, the
reactions were fast and efficient, and both secondary and tertiary amides underwent clean
chain extension to 30. When comparing reactions o f the P-keto esters, amides, and
phosphonates, the relative rates of chain extension appeared to be more consistent with
rate of complexation o f the zinc to the P-keto functionality than with the pKa of the aproton. 19
The lowest yields in the chain extension of the P-keto amides (entries a, b and e)
were for products which were very water soluble, suggesting a loss of material in the
aqueous workup. It is interesting to note that the presence of acidic protons (entry b, f,
and h, and especially e) did not inhibit the reaction. In contrast to the overreactivity o f a substituted P-keto esters 1 , substituents at the alpha position of the P-keto tertiary amides
inhibited the reaction. The lack of reactivity of the amide substrates was attributed to the
lowered acidity of the alpha proton, which lies nearly orthogonal to the n-system to
minimize A(l,3) steric interactions. 20

Introduction to Transition State Analogs
Since the initial discussions by Pauling regarding enhanced transition state
binding between a substrate and an enzyme, medicinal chemists have attempted to apply
this principle to drug design. 21 Wolfenden spearheaded the focus on compounds referred
to as transition state analogs, which are substances designed to mimic the transition state
and thereby having the strongest interaction between enzyme and substrate. 2 2 Features
found in the active site which stabilize the transition state are also believed to stabilize the

10
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tetrahedral intermediate 32 o f peptide bond hydrolysis (Figure 1). Transition state
analogs for proteases have targeted this tetrahedral intermediate. The tendency for amide

hydrolysis

^

Figure 1. Isosteric Amide Bond Replacements

bonds to undergo hydrolysis (usually enzyme-mediated) has driven the development of
non-peptidic isosteric replacements of the amide bond in protease inhibitors. 23 Common
isosteric replacements include the ketomethylene (33), hydroxyethylene (34), and
difluoroketomethylene (35) groups.

Previous Means of Preparing Ketomethvlene Isosteres
The attractiveness of preparing a peptidomimetic which can be involved in
hydrogen bonding, yet is not susceptible to hydrolysis has driven the development of the
ketomethylene isosteric replacement (33, Figure 1) for the peptide amide functionality.
The ketomethylene unit has been utilized in the development o f inhibitors to a wide
variety o f enzymatic systems, including HIV protease, 2 4 DJD-carboxypeptidasetranspeptidase (final step in bacterial cell wall assembly) , 2 5 aminopeptidase, 2 6 and snake

11

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

venom angiotensin converting enzyme (ACE) , 2 7 as well as in the generic serine
proteases. 28
The synthetic challenge of preparing these compounds has previously been met in
a variety o f ways. One common approach has been to attack an aldehyde (37) with a
grignard reagent (36, Scheme 8 ). Unfortunately, epimerization of the stereocenter at R”
is often observed in the formation of the y-hydroxy acid and the oxidation to 38 can

B rM g v ^ ^ /O B n 36

oxiaauon

38

Scheme 8 . Generation of y-Keto Ester Using a Grignard Reagent

be troublesome. 29 A similar approach was used in the preparation of snake venom ACE
inhibitors, although the grignard reagent was simply derived from 4-bromobut-1-ene.
Ester functionality was then incorporated by oxidative cleavage of the olefin. 3 0
Another method for generation of y-keto ester functionality involves displacement
o f an a-bromo (or other good leaving group) carbonyl by a malonate or similar stabilized
enolate. Two variations on this strategy are illustrated in Scheme 9. The first approach
utilizes an electrophilic ester (40) which is reacted with the salt of a p-keto ester (39).
Displacement has been reported with optically active substrates (R’ * H) and results in
the generation o f peptide isosteres with an a-substituent 31 The second approach uses a

12
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O
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° c H 3
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o

R"

C0 2 CH3

2. NaOH
45

Scheme 9. Formation o f y-Keto Esters via Displacement of a Leaving Group

malonate anion to effect displacement of an activated bromide 42. Alkylation and
decarboxylation can provide access to a-substituted systems like 45, although the
challenge o f controlling stereochemistry remains. 32

Formation of Transition State Analogs
O f top priority will be the general application o f the zinc-mediated chain
extension reaction to peptide systems in order to develop a general methodology for
formation o f the isosteres described above. The preparation o f P-keto ester derivatives of
a number o f N-protected amino acids will be required and the effectiveness of the chain
extension reaction on these substrates will be tested. Amino acids which contain polar
groups on the side chains, like aspartic acid, asparagine, serine, and lysine will be utilized
in a second phase o f the study. Furthermore, the zinc-mediated chain extension will be
attempted on resin-bound p-keto esters as a possible means o f generating isosteric amide
bond replacements on solid supports. Ultimately, the incorporation of a ketomethylene
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amide bond isostere in an amino acid sequence will be attempted to test the efficiency of
the zinc-mediated chain extension reaction in a synthetic sequence.
Human cytomegalovirus (HCMV) is a pathogen recognized as a significant health
risk to neonates and immunocompromised patients. 33 Since the replication and assembly
o f HCMV is dependent on a serine protease, 3 4 the targeted inhibition of this protease
presents an attractive strategy for disruption of this virus’ life cycle. The amino acid
sequence Val-Asp-Ala-Ser has been determined to be necessary for site-specific
recognition by this serine protease, 3 5 with cleavage occurring at the Ala-Ser bond. An
ideal starting point for isosteric amide bond replacement would be at this site. A good
model of ketomethylene isosteric amide bond replacement using the zinc-mediated chain
extension reaction would include the Asp-Ala sequence followed by the isostere, then

0

CH,

O

CH3

BocHN

O

46
A la

isosteric additional
amide bond amino acid
replacement

Figure 2. Possible Target Molecule Containing Ketomethylene Isostere

an alanine incorporated on the carboxy terminus to demonstrate the possibility of further
functionalization in that direction. The successful preparation o f 46 (Figure 2) would
demonstrate the applicability o f the zinc-mediated ch a in extension reaction to the
generation o f polypeptidyl isosteres.

14
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DISCUSSION OF RESEARCH

Protected Amino Acid*
A variety o f N-protected amino acids were required for this study. Most of the Nprotected alkyl side-chain containing amino acids 48 (Figure 3) were prepared using
Schotten-Baumen conditions36 in which aqueous base is used as solvent to capture the
HC1 expelled by reaction o f an amine with an acid chloride or chloroformate. Benzyl
O
H’NY Jt'OH
R
47

Boc

H

O

N~Pr0 1 eCtj0n

P^Y ^O H
R
48
P = Boc, Cbz, Bz, Fmoc

Cbz

Bz

Fmoc

Figure 3. Common N-Protective Groups for Amino Acids

chloroformate, benzoyl chloride, and 9-fluorenylmethyl chloroformate were used to form
the Cbz, 37 Bz, and Fmoc38 protective groups respectively, whereas Boc anhydride was
used in the installation of a Boc group. 3 9 For protection with Cbz, it was later found that
a simple procedure utilizing benzyl chloroformate and dry EtOAc as a solvent worked
effectively in place o f Schotten-Baumen conditions.4 0
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Masamunc-Brooks Reaction
Since a majority o f the compounds prepared in this study require p-keto ester
functionality, a mild and effective means of producing P-keto esters from N-protected
amino acids was needed.
A standard method for the generation of p-keto esters is through a Claisen
condensation (Scheme 10). Activation of the carboxylic acid 48 through the acyl

li
pV

O
°

1) activation
h

2)
4g

H 9

—
?
^O M e

p'

N' A
R
50

9
A

om,

49

Scheme 10. Claisen Reaction

imidazole, 41 acid chloride, 4 2 or mixed anhydride4 3 and treatment with an enolate 49 is a
straightforward means of obtaining P-keto esters 50, yet there was concern about possible
epimerization of the stereocenter at the R-functionality (the amino acid stereocenter).
It was discovered at an early stage that P-keto ester derivatives of amino acids
could be consistently produced using the method of Masamune and Brooks (Scheme
l l ) . 4 4 In this reaction, the acyl imidazole 51 of the N-protected amino acid 48 is exposed
to a magnesium salt o f monomethyl malonate, producing the P-keto ester 50 under
mildly basic conditions. The mechanism is thought to proceed via deprotonation of the
dimeric species 52 by the equivalent of imidazole left in solution. Subsequent attack of
53 on the acyl imidazole 51 results in p-keto ester 50 formation.
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Scheme 11. Mechanism o f the Masamume-Brooks Reaction

In the first series o f reactions studied, the racemic N-protected amino acids 48
were dissolved in THF and treated with carbonyldiimidazole (CDI).

Following gas

evolution, the acylimidazole solution was added to a white slurry of the magnesium salt
of monomethyl malonate (MMM) in THF formed by mixing a 2:1 ratio of MMM to
Bu2 Mg. When methylene chloride was used as the reaction solvent, the monomethyl
malonate salt was dissolved completely and the yields of the reactions of FMOCprotected amino acids (entries n-q) improved. Typically, the reaction proceeded quickly
to 40-60% conversion, but lengthy stirring (1-3 days) always improved the yield. The
completed reaction was partitioned between saturated NH 4 CI and Et2 0 . Chromatography
on silica was necessary to isolate the amino acid-derived P-keto ester 50. The glycinederived products (a, e, j, n) required much more polar solvents for column
chromatography and were less soluble overall, resulting in decreased yield of purified
products in these cases.
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Table 4 shows the results of the first series of Masamune-Brooks reactions.
Low yields only occurred (entries g, h, Ic, 1) when the solubility o f the products made

9
N

l.)CDI/THF
9 |?
------------- * P+tNY J ^ O M .
2 .) MgBu 2 /THF
r
monomethyl malonate
5 0

V w
R
4 8

P

R

•/•yield 50

a

BOC

H

91

b

BOC

Me

70

c

BOC

Ph

41

d

BOC

Bn

63

e

Cbz

H

65

f

Cbz

Me

66

g
h

Cbz

iPr

34

Cbz

Ph

45

i

Cbz

Bn

71

i
k

Bz

H

65

Bz

Me

47

1

Bz

Ph

28

m

Bz

Bn

74

n

Fmoc

H

65

0

Fmoc

Me

63

P

Fmoc

Ph

72

4

Fmoc

Bn

64

entry

12

Table 4. Masamune Brooks Reaction ofN-Protected Amino Acids

column chromatography on silica difficult. Otherwise, the reaction was consistently
efficient The spectra of the reaction products were compared to literature data of
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material made through alternate methods4 5 and also via the Masamune-Brooks protocol
(e.g. 50b46).

Masamune-Brooks Reaction Modifications
If further functionalization o f 50 was to be accomplished, then a means of
unmasking the carboxy terminus was necessary. The acidic or basic conditions required
for saponification o f the methyl ester were assumed to be too harsh, since

1.) CPI. THF
phn
U
2.) MgBu2, THF
X
0

0

1 0 J 4 M 9 P - H n J L A . oh
EtOH
r

R 55

*

H O '^ '^ O B n
monobenzyl malonate
("MBM")

-C 0 2

t Q
P -H N ^ J k
R
57

Scheme 12: Using Monobenzyl Malonate in the Masamune-Brooks Reaction

epimerization o f the stereocenter present in the amino acid was a concern. Monobenzyl
malonate (MBM) was considered to be a practical alternative to monomethyl malonate in
the Masamune-Brooks procedure, since the benzyl ester in 55 could be removed by
hydrogenolysis (Scheme 12), making the carboxylic acid available in 56 for further
chemistry. When the modified Masamune-Brooks reactions were attempted with
monobenzyl malonate, an increased solubility of the malonate salt in THF and shortened
reaction times were observed, no longer necessitating an overnight stir. It is not firmly
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established, however, that the increased solubility of the malonate salt is solely
responsible for the shorter reaction times.
A test hydrogenolysis of the benzyl ester of racemic 55d (R = Bn, P = BOC)
cleanly gave free (3-carboxylic acid 56d, yet it readily decarboxylated during
concentration from ethanol (aspirator vacuum, 60°C) to give the methyl ketone 57d (R =
Bn, P = BOC). Compound 57b (R - Me, P = BOC) was in fact a volatile liquid which
pumped off under any vacuum greater than that of the aspirator. If care was taken to keep
56 cool during concentration, 57 was not observed.
Seeking to further expand the Masamune-Brooks protocol, it was thought that use
of the alanine-derived (3-acid 58 (Scheme 13) in the reaction would offer a direct route to
compounds such as 59, and subsequent chain extension chemistry could produce the
ketomethylene isosteric amide bond replacement in 60.

o

a-) CDI
4 8 — ......... *

P-HN

b.) Bu2Mg
Ph
O O
tf^rn
HO' v

^ Ph

X jU! IU
rR

M

H

0

CH 2 C 12

O

«

O

M
V'P h

00

59

OMe
'N ^ S < C
H
IJ
H O

58

Scheme 13: A Modified Masamune-Brooks Procedure

Preparation o f 58 was first accomplished by treating L-alanine methyl ester 61
with Meldrum’s acid (62, Scheme 14).47 The Masamune-Brooks reactions attempted
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with 58 were unsuccessful, however, and it was speculated that residual Meldrum’s acid
in 58 (nearly impossible to remove because of its similar solubility and acidity) was

p s

T

f

%

o

o

”

J

^
61

X “ e0 Y i 'N 'll^ JL'OH
reflux
o H
THF or toluene
58

Scheme 14: Use of Meldrum's Acid to form 58

present, perhaps leading to protonation of the magnesium complex 53 (Scheme 11),
therefore stopping its reaction with the acyl imidazole.
A less direct route (Scheme 15)48 to 58 was conducted in which the acid chloride
of monobenzyl malonate was reacted with (L)-alanine methyl ester 61 to form the benzyl

0 0
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Scheme 15. Alternate Formation of Modified Masamune-Brooks Starting Materials

ester 63, which was easily converted to 58 through hydrogenolysis. Decarboxylation was
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avoided by removal o f the solvent by rotary evaporation using only very mild heating.
Since the amide proton o f 58 was also speculated to interfere in the Masamune-Brooks
reaction, the N-benzyl substrate 6 6 was prepared as well.
Unfortunately, Masamune-Brooks reactions between N-protected amino acids and
58 or 6 6 were also unsuccessful, indicating that the purity of 58 and 6 6 or the presence of
the amide proton in 58 were not the cause of interference in the reaction. The reaction
mixtures were homogenous upon addition of dibutylmagnesium, yet formation of 59 was
not suggested by TLC or observed after workup and column chromatography.
Substitution at the a-site (R’) of the P-keto ester 69 was also desired in order to
test the viability o f the zinc-mediated chain extension reaction conducted with asubstitution present. Formation of these a-substituted P-keto esters 69 was initially
attempted using a modification of the Claisen-like conditions first reported by Cowan et
al4 9 (Scheme 16) in which the enolate of a TMS-ester 67 is reacted with an activated
carbonyl compound. The trimethylsilyl ester 6 8 could be easily converted to

4g

a.) CPI
b)

0 0
?
U
P-HNYJS ^ 'O S iM e J M K M ^ V V ^ O M e

OLi
1
|^ O S iM e 3
R* 67

R

R’

HC1 (anhyd.) R

68

R'
69

Scheme 16. Approach to a-substituted P-keto esters

the methyl ester with an anhydrous HCl/methanol workup. 5 0 Unfortunately, the
imidazole present from the use of CDI in the formation of the acyl imidazole reacted in
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the highly acidic conditions, so neither products 6 8 or 69 could be recovered.
Another approach utilized BF3-etherate in a modification of conditions normally
used for esterificationsl of carboxylic acids 70 (Scheme 17). It was speculated that a

O
R ^O H

a.)BF 3 (0Et ) 2
b.) MeOH/HCl R

71

0Me

O O
a.) 4 eq. BF^OEtyEtzO P*HNV J L A (
b.)

0°

R

f^ O S iM e 3

R*
69

R' 67
c.) MeOH/HCl

Scheme 17: Another Approach to a-Substituted P-Keto Esters

BF3-activated carboxylic acid would be susceptible to nucleophilic attack by the enolate
of TMS-acetate 67. The reactions yielded no detectable amounts o f products and this
approach was dropped due to the limited reactivity of the N-protected amino acid starting
materials 48.
The use o f a-substituted mono-alkyl malonates in the Masamune-Brooks reaction
was also explored in the preparation of a-substituted P-keto esters 69 (Scheme 18). In
the original publication by Masamune and Brooks, 32 it was reported that successful
neutral C-acylation occurred using a-substituted mono-alkyl malonates and mono-alkyl
malonate half-thiol esters. Compounds 72a and 72b were prepared in order to generate
the products 69a and 69b. These reactions were wholly unsuccessful, however, and
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also tried:
O O

a.) CDI

48

b.) Bu2Mg
O O

R

R'

HO

69 a. R' = Me
b. R' - Bn

R’

73 a. R’ = Me
b. R' = Bn

72 a. R' - Me
b. R' = Bn
substituted
monomethyl malonates

Scheme 18: a-Substituted Mono-Alkyl Malonates in the Masamune-Brooks Reaction

products were barely observable by NMR of the crude reaction mixture. The use of asubstituted monobenzyl malonates 73a and 73b was also attempted with no success.
Variation in temperatures and solvents were screened, but to no effect. Considering the
problems with these reactions and the previously observed difficulty in chain extending
a-substituted P-keto esters, the attempts at generating p-keto esters with a-substitution
were dropped.

The Zinc-Mediated Chain Extension Reaction
The chain extension was initially conducted on the P-keto methyl esters 50 (Table
5) to test the reaction conditions with a number of different protective groups. The
reactions were typically performed on a 0.25 to 0.5 mmol scale at 0.04 M concentration
o f carbenoid. The carbenoid was prepared by adding 5.0 eq Et2 Zn into a 0 °C solution of
7.5 eq. CH 2 I2 in CH2 CI2 and stirring 2 min. The 7.5/5.0 ratio o f methylene iodide/diethyl
zinc was determined to be the most efficient after a series o f test reactions were
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conducted. The use o f five equivalents o f carbenoid generated in this manner shortened
ZnEt2 /CH 2 l 2 p - H N ^ J L ^ ^ O M e
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Table 5. Chain Extension Reactions of Amino Acid-Derived p-Keto Esters

reaction times and minimized the appearance of side products. Reactions that utilized
three or four equivalents o f carbenoid often showed traces of residual starting material,
presumably due to the quenching o f a small portion o f the carbenoid by traces o f water
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contained in the solvent or starting material. Additionally, excess methylene iodide
eliminated the possibility o f free diethyl zinc in solution which could behave as a
nucleophile or as a base and facilitate the generation o f side products. The use o f an 8 /S
or

10

/S ratio o f methylene iodide/diethyl zinc only seemed to increase the amount of

methylene iodide present after workup and did not improve the yield of y-keto ester.
After formation of the carbenoid, the ice bath was removed and a CH2 CI2 solution
of the starting P-keto ester was added rapidly. The reaction was monitored by normal
phase TLC until complete, with product (74) spots appearing at a slightly lower fy than
starting materials in all of the reactions. Visualization of product formation was much
easier with anisaldehyde stain, as the product and starting material spots appeared as
different colors.
The reaction was often complete within IS minutes and never took more than an
hour at room temperature. When the reaction was complete, it is washed with saturated
NH4CI solution, dried with MgS0 4 , and concentrated. The crude material was

chromatographed on silica using EtOAc in hexane. Competitive side product formation
seemed to occur with the Boc-glycine substrate 50a, but a five minute reaction time
minimized side product formation (at a cost to yield). Glycine-based products were less
soluble in organic solvents and required more polar solvents for chromatography (50%
EtOAc/hexane was typical). Various spectra of the products were confirmed by
comparison to literature sources. 53
After these initial reactions were performed, we addressed the concern that
epimerization might be occurring in the Masamune-Brooks and/or chain extension
reactions. Since a convenient method for the determination o f optical purity was
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Scheme 19: Racemization Occurring in Phenylalanine Series

needed, chiral HPLC was selected for the analysis of the y-keto ester products from
reactions with enantiomerically pure starting materials. Both a D,L mixture and a single
enantiomer of the Boc-L-phenylalanine-derived Masamune-Brooks product (55d) and
chain extension product 75d were prepared and compared on a Daicel Chiralpak® ADRH reverse phase chiral column (Scheme 19). The benzyl esters were selected for use
with the UV-vis detector. The phenylalanine derivatives S5d and 75d readily separated
using 5% H 2 0/MeOH and it was observed that 10% racemization occurred during the
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Scheme 20: Racemization Occurring in A lanine Series
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formation o f the Masamune-Brooks products (giving an 80% ee). Most significantly,
there was no further racemization noted during the chain extension reaction.
Separation o f the Boc-alanine Masamune-Brooks product 55b was not possible
using various ratios o f acetonitrile/water and methanol/water, so it was converted to the
Cbz-protected analog 55f, which separated well using 100% MeOH (Scheme 20). Again
racemization was noted in the Masamune-Brooks product 55f, but no further
racemization was noted in the chain extension product 75d.

O
a.) CDI
(L H 8 1
(Bz-L-PheGly)b.)MMM,
MgBu2 THF

0

, Et2 Zn, CH 2 I2 BzHN
*

CH2 C12

ph - 4 |

ft

501

10% H 2 0/MeOH
1 0 0 % racemized

10% H2 0/MeOH

Scheme 21: Racemization Occurring in Phenylglycine Series

With phenylglycine, the only effective separation was obtained using the benzoyl
(Bz) protected Masamune-Brooks methyl ester product 5 0 1(Scheme 21). hi this case,
complete racemization occurred during the Masamune-Brooks reaction to give racemic
501. No information on racemization during the chain extension reaction to form 741
could thus be attained.
A couple o f other observations were noted when using the Daicel Chiralpak®
AD-RH reverse phase chiral column (Figure 4). The racemic Cbz-phenylglycine
Masamune-Brooks product 50h readily separated with 10% H2 0/MeOH, but compounds
like 76 (analogous to 63) appeared to be far too lipophilic for the column, indicating that
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the carbamate linkage facilitates easy separation o f enantiomers on the reverse-phase
Daicel column.

CbzHN

76

50 h

Figure 4: Additional Compounds Studied by Chiral HPLC

A further test o f stereochemical integrity was conducted as in Scheme 22. The pketo ester 55b (87% ee, per Scheme 20) derived from Boc-L-alanine was subjected to
chain extension conditions to give 75b. The carboxylic acid 77b, obtained by
hydrogenolysis, was then coupled to the L-phenylalanine methyl ester 61. As expected,
no decarboxylation of y-keto esters 75 occured as observed with the P-keto esters 55,
even with mild heating o f the acid 77 during concentration from ethanol. No
epimerization o f the stereocenters was observed in the product 78, as only one

n

O

O

BOCHISJ A
1.) CDI, THF B o c H N ^ A A
Y ^ 0H 2.)
2 .) MBM, r
I
'
«CK

u

ZnEt2, CH2 I2 BocHN
CH2 C12
75b
naa/
79%
EDC, HOBt
Et,N, DMF

BocHN

BocHN

Scheme 22: Formation of an Isosteric Replacement
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OBn
O

diastereomer was present by NMR. It should be noted that the chromatographic
separation o f 78 may have contributed to its diastereomeric purity through separation of
the minor diastereomer. The high mass recovery o f 78 suggested that the minor
diastereomer was present only in trace quantities, if at all.
Reports in the literature3 4 and unpublished observations from our laboratory33
indicate that N-methylation has the potential to be a competing reaction when zinc
carbenoids are present (Scheme 23). A systematic survey o f functionality at this

79

50

Scheme 23: Potential N-Methylation Side Products in the Chain Extension Reaction

nitrogen, which included amide, Boc, Cbz, and FMOC derivatives revealed no trace of Nmethylated chain extended side products 79.

Different Side Chain Attempts

In addition to the alkyl side chains, a study of amino acid derivatives with polar
side chains (Table 6 ) was undertaken. Since acidic protons would hinder the MasamuneBrooks and could potentially affect the chain extension reactions, protection of the side
chains was required. The serine, aspartic acid and lysine residues were thus masked with
protective groups, while the asparagine side chain was left intact, since primary amide
functionality has been shown to be tolerated by the chain extension reaction. 3 6 The
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Table 6: Polar Side-Chain Functionality

O-benzyl aspartate and Boc-lysine derivatives 55r-u and 75r-u were easily formed, while
problems occurred with the asparagine and O-benzyl serine series. The MasamuneBrooks reactions o f the asparagine substrates provided only a small yield of the product
80 containing a dehydrated asparagine side chain. The poor solubility of the asparagine
derivatives in THF contributed to a longer reaction time, and the small amount of desired
product formed was immediately converted to the dehydrated material under MasamuneBrooks conditions. Chain extension reactions to form 75v have not been attempted. The
O-benzyl serine Masamune-Brooks products 55w and 55x formed easily, but many side
products were observed in the chain extension reaction. It was difficult to determine the
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structures o f these side products, but they appeared to have a low molecular weight,
indicating a significant decomposition of the starting material under chain extension
conditions.
The integrity of the stereocenter during the Masamune-Brooks and chain
extension reactions was tested on the di-Boc-L-lysine substrates 55a and 75a using the
aforementioned Daicel Chiralpak® AD-RH reverse phase chiral column. Both were
readily separable using 10% HzO/MeOH and, as before, 10% of the Masamune-Brooks
product 55a was racemized, whereas no additional racemization was noted after the chain
extension reaction to form 75u.

Ketomethylene Isostere via the Chain Extension Methodology
In order to test the applicability o f the chain extension methodology to actual
synthetic examples, an analogue of a potential inhibitor5 7 of human cytomegalovirus
(HCMV) protease 8 6 was constructed in which the cleavage site between the alanine and
serine residues was replaced with a ketomethylene isosteric amide bond replacement
(Scheme 25). Following DCC coupling of Boc-L-asparagine L-48u to the benzyl ester of
L-alanine to form the dipeptide 81, the carboxylic acid 82 was cleanly unmasked by
hydrogeno lysis. The acid was then subjected to Masamune-Brooks conditions to form
the P-keto ester 83. Initially the reaction to form the dipeptide 81 appeared to occur in
very low yields, but it was discovered that the isolated material was in fact the nonpolar
nitrile side product resulting from DCC-induced dehydration of the asparagine side chain
residue. The nitrile 80 was easily recognizable by its unique 13C NMR resonance at
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@116 ppm. Formation of the insoluble and highly polar asparagine-containing product
81 was not detected until more polar TLC solvent systems were utilized.
O
BocHNv ^ X |
H2N ^ J

* 'T
OBn
- HCl

O a
BocHNV ^ N^ Y ° B n

HOBt, Et3N
DCC, CH2 C12

H2N

^
I
B o c H N ^ X j^ A y

I

L-48u

Scheme 24. Side Product Resulting from Dehydration o f Asparagine Side-Chain

It should be noted that all of the products in this synthesis, starting with 81,
exhibit poor solubility in standard low boiling solvents, including THF, MeOH, CH2 CI2
and Et2 0 . This posed a problem initially, as the Masamune-Brooks and chain extension
reactions were typically run in THF and CH2 CI2 , respectively. It was discovered (out of
necessity) that the acyl imidazole intermediate of the Masamune-Brooks reaction could
be formed in DMF and then added to the preformed magnesium malonate complex in
THF. The use o f DMF as a solvent did not appear to noticeably inhibit the reaction here,
even though previously attempted Masamune-Brooks reactions on Boc-asparagine using
DMF as the solvent resulted in dehydration of the asparagine side chain as with 55v.
The chain extension reaction was conducted by adding solid 83 directly to the
preformed zinc carbenoid in CH2 CI2 . Formation o f y-keto ester 84 was extremely rapid
after addition o f starting material and the reaction ran very cleanly, but column
chromatography was conducted on 84 in order to rid the product of any residual zinc salts
and methylene iodide. Flash chromatography of the amino acid derivatives in Scheme 25
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Scheme 25. Formation of Ketomethylene Isosteric Amide Bond Replacement

on silica was limited to MeOH/CH2 Cl2 solvent systems, as the insolubility and polarity of
the derivatives due to the presence of asparagine prevented the use of EtOAc/hexane. To
this end, flash chromatography was only conducted on 84 and 8 6 to m inim ize the loss of
material. All of the other products were purified by aqueous extraction of leftover
reagents, followed by recrystallization.
After hydrogenolysis o f the benzyl ester in 84 to form 85, the final am ino acid
residue was coupled with DCC to the methyl ester of L-alanine to complete the sequence
to 8 6 . Yields were very good in all of the steps, further demonstrating the applicability of
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the zinc-mediated chain extension reaction toward the generation o f ketomethylene
isosteric amide bond replacements.

Application to Solid Phase Combinatorial Chem istry
Most solid phase peptide chemistry5 8 involves binding the amino acid to the
support through the carboxylate and building the peptide chain toward the N terminus.
This is done to minimize both racemization of the stereocenter and oxazolidinone
formation. A simple system needed to be constructed to see whether the zinc-mediated
chain extension reaction was useful around polystyrene resins and their associated linkers.
Retrosynthetically, the easiest way to build a simple system analogous to the examples
studied herein and perform the chain extension on a solid support would be to bind the
nitrogen end of the amino acid to the resin and construct a (3-keto ester from the carboxy
terminus. The benzyl carbamate linker of the Wang59 resin was not expected to inhibit
the reaction.
Towards this end, the N-terminus of an amino acid was attached to a Wang resin
using previously reported chemistry. 6 0 hi this procedure (Scheme 26), the Wang resin
was activated through treatment with p-nitrophenyl chloroformate to give 87.
Displacement o f the p-nitrophenyl group with allyl-protected L-phenylalanine was
accomplished in DMF with Hunig’s base added to free the amine from its salt form. The
allyl ester of

88

was transformed to the free acid 89 by treatment with palladium(O) and

morpholine in THF. A Masamune-Brooks reaction on the acid proceeded very cleanly to
give the (3-keto ester 90. The P-keto ester formation was dependent on treatment of the
resin-bound acid with a significant excess o f GDI and thorough washing of the acyl
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Scheme 26: Attempted Solid Phase Synthesis

imidazole with THF before exposure to the magnesium/malonate complex in THF.
Quenching the reaction with 5% AcOH/THF and rinsing the resin thoroughly with SO/SO
water/THF effectively provided the resin-bound P-keto ester. After each of these steps, a
sample o f the dried resin was treated with CH2 CI2 /TFA and the product TFA salt weighed
to determine the resin loading. Analysis o f the cleaved material by NMR indicated that
all of the reactions to this point occurred cleanly. The loading of the material on the resin
did not significantly decrease in any of the steps, indicating cleavage o f material from the
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resin was not occurring in the reactions, hi each step, only clean products were obtained
after cleavage.
Although many variations in library assembly could be envisioned from a resinbound P-keto ester, we were primarily interested in exploring the compatibility of the
chain extension method with the resin-bound P-keto ester. The chain extension
methodology allows for the general incorporation of a methylene unit in the individual
compounds. Following cleavage from the resin, large varieties of inhibitor analogs with
isosteric amide bond replacements can be created in only a fraction of the steps currently
necessary.
The resin-bound P-keto ester 90 was exposed to chain extension reaction
conditions that used variations in reaction times, concentrations o f carbenoid, and
quenching methods, but, unfortunately, none of the chain extended product 91 was
isolated. In fact, very little material was recovered at all from the resin after the chain
extension reaction, leading to the speculation that the zinc carbenoid solution is simply
too harsh an environment for the resin to withstand. Extensive washing o f the resin was
conducted after the reaction in order to rule out the possibility o f zinc salts “clogging” the
resin, but no product was recovered. The resin was also exposed to the carbenoid for less
than one minute to see if some starting material could be recovered, but none was visible
after cleavage from the resin. The reaction was also quenched in a variety of ways,
including the use o f 5% AcOH in CH2 CI2 , SO/SO water/THF, and addition of a saturated
ammonium chloride solution to the resin suspended in CH2 CI2 . Finally, the resin-bound
amino acid 89 was treated briefly with carbenoid and quenched with 5% ACOH/CH2 CI2
before thoroughly rinsing and drying the resin. No material was isolated after attempted
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cleavage of resin-bound products, leading to the conclusion that the carbenoid is in fact
cleaving the substrate from the resin before chain extension is occurring.
The lack of success in these attempts leads us to believe that the Wang resin may
not be appropriate for use in the zinc-mediated chain extension reaction. It is possible
that a carboxy-terminus bound amino acid-based P-keto substrate might be more
appropriate when using the zinc-mediated chain extension on solid supports.

Conclusions
The zinc-mediated chain extension reaction has been demonstrated to be of
practical synthetic utility in the construction of N-protected amino acid-derived y-keto
esters from P-keto esters. With a variety of alkyl side chain functionality, as in alanine,
phenylalanine, and phenylglycine, the reaction proceeded without significant production
o f side products. However, the yields were only marginal if the starting material or
products were especially insoluble or otherwise difficult to purify.
Amino acids with protected non-alkyl side chains like aspartic acid and lysine
underwent chain extension without incident, yet serine derivatives appeared to markedly
decompose in the presence o f the zinc carbenoid. Asparagine, with its primary amide
side chain functionality was not easily converted to a P-keto ester substrate, since its
solubility in the solvents used for this transformation was limited. If the asparagine side
chain was separated from the carboxy terminus by an amino acid containing an alkyl side
chain (such as alanine), the solubility o f the molecule was sufficient for both the the
Masamune-Brooks and chain extension reactions.
The amino acid stereocenters of alanine and phenylalanine are epimerized
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slightly during the production of the P-keto ester substrates, yet further epimerization is
not observed during the zinc-mediated chain extension reaction, indicating that the
reaction has a promising future in the chain extension o f substrates which contain
stereocenters.
The incorporation o f a ketomethylene isosteric amide bond replacement in
tripeptide- and tetrapeptide-analogues was easily accomplished using the zinc-mediated
chain extension reaction. The synthesis o f these molecules proceeded without noticeable
epimerizadon o f the am ino acid stereocenters and even worked well in the presence of the
asparagine side chain, which inhibited the Masamune-Brooks and chain extension
reactions of Boc-asparagine.
The chain extension of resin-bound P-keto esters to y-keto esters was not
successful even after a variety o f conditions and workups were attempted. This
disappointing result seems to occur through actual physical damage o f the resin by the
zinc carbenoid. Alternative linkers, including carboxy-bound amino acid supports,
should be investigated for their suitability in facilitating solid phase chemistry.
Fortunately, the vast majority of amino acid syntheses on solid supports is accomplished
through attachment o f the carboxy terminus to the resin and construction outward toward
the N-terminus, so the zinc-mediated chain extension may prove to be of some utility in
solid phase synthesis in the future.
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EXPERIMENTAL

General Experimental
All reactions were run in oven-dried glassware under nitrogen atmosphere and stirred
with teflon-coated magnetic stir-bars. The terms concentrated in vacuo or under reduced
pressure refer to the use o f a rotary-evaporator. Methylene chloride was distilled from
phosphorous pentoxide. Ethyl acetate and hexanes were distilled prior to use. Reagents
were purchased from commercial suppliers and used without further purification. Diethyl
zinc was used as a

1 .0

M solution in hexanes. Methylene iodide (CH 2 I2 ) was purchased

from commercial suppliers and non-oxidized copper wire was added as a stabilizer.
Column chromatography was performed on EM Science flash silica gel (35-75pm).
Mobile phases were used as noted. Thin Layer Chromatography (TLC) was carried out on
EM Science F2S4 glass plates and visualized by UV and anisaldehyde or
phosphomolybdic acid stains. The {^values were determined with the same solvent used
for column chromatography. Low Resolution Mass Spectroscopy was performed by the
University o f New Hampshire Instrumentation Center on a Perkin-Elmer 2400 Analyzer.
High Resolution Mass Spectroscopy was performed at Merck Pharmaceutical Research,
West Point, PA. NMR spectroscopy was performed on a Broker AM360.
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Representative Procedures and Data

Formation of the 0-Keto Methyl Ester (Masamune-Brooks procedure)

Methyl 4-(carbobenzyloxy)amino-3-oxo-5-phenyl-pentanoate (50i)
Into a 25 mL round-bottomed flask equipped with a stir bar were placed 300 mg (1.00
mmol) Cbz-phenyalanine (481) and 10 mL anhydrous THF. Carbonyl diimidazole (CDI)
(178 mg, 1.10 mmol) was added and the solution stirred until gas evolution ceased
(approximately IS minutes). In a separate 100 mL round-bottom flask which contained a
solution o f monomethyl malonate (352 mg, 3.00 mmol) in 30 mL of anhydrous THF was
added 1.SO mL (1.S0 mmol) of a 1M hexane solution of dibutylmagnesium at 0 °C. This
solution, which appears as a white slurry, was allowed to warm to room temperature. The
acyl imidazole solution was transferred in one portion to the flask which contained the
magnesium salt and the reaction was monitored by TLC. The solution was allowed to
stir for 48 hours and quenched by the addition of 30 mL sat. aq. NH4 CI solution. The
solution was extracted three times with 20 mL EtjO. The combined organics were dried
with MgS04, filtered, and concentrated. The crude residue was chromatographed on
silica with 15% EtOAc in hexanes to yield 252 mg (71%) of 50i as a colorless oil: *H
NMR (360 MHz, CDCI3 ) 8 7.39-7.23 (m, 8 H), 7.15 (m, 2H), 5.35 (d, 1H, J = 7.7 Hz),
5.12 (s, 2H), 4.67 (m, 1H), 3.70 (s, 3H), 3.55-3.43 (m, 2H), 3.19-3.14 (dd, 1H, J= 6.1,
14.0 Hz), 3.04-2.98 (dd, 1H, J = 7.1,14.0 Hz); l3C NMR (90 MHz, CDCI3 ) 8 201.6,
167.3,155.8,136.2, 135.8,129.2,128.8,128.5,128.2,128.1, 127.2,67.1,60.8,52.4,
46.7,36.9. HRMS (M +N af calculated 378.1312, found 378.1305 for C ^ iN iO s N a .
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Methyl 4-(carboxy-t-butyl)-amino-3-oxo-butanoate (50a)
91 %, yellow oil; lH NMR (360 MHz, CDC13) 8 5.22 (bs, IH), 4.11 (d, 2H, 7 = 5.1 Hz),
3.72 (s, 3H), 3.49 (s, 2H), 1.43 (s, 9H); l3C NMR (90 MHz, CDC13) 8 198.6, 167.0,
155.6.80.1.52.5.50.5.46.2.28.2.

(±)-Methyl 4-{carboxy-t-butyl)-amino-3-oxo-pentanoate (50b)
70 %, white soUd; mp = 52-54 °C: lH NMR (360 MHz, CDC13) 8 5.15 (bs, 1H), 4.36 (dq,
1H, > 7 .0 ,7 .0 Hz), 3.73 (s, 3H), 3.50 (d, 1H, 7 = 15.7), 3.40 (d, 1H, 7 = 20.0), 1.43 (s,
9H), 1.36 (d, 3H, 7 = 7.0 Hz); 13C NMR (90 MHz, CDCI3 ) 8 202.3,167.5,155.3,80.0,
55.3.52.4.45.5.28.2. 16.9.

(±)-Methyl 4-(carboxy-t-butyl)-ainiiio-3-oxo-4-phenylbutanoate (50c)
41%, colorless oil; lH NMR (360 MHz, CDCU) 8 7.54-7.29 (m, 5H), 5.82 (bs, 1H), 5.44
(m, 1H), 3.65 (s, 3H), 3.48 (d, 1H, 7 = 16.0 Hz), 3.33 (d, IH, 7 = 16.0 Hz) 1.40 (s, 9H);
l3C NMR (90 MHz, CDCI3 ) 8 198.3,166.6, 154.7,135.7,129.3,128.8, 128.1,80.1,64.4,
52.4.45.8.28.2. HRMS (M+Na)+ calculated 330.1312, found 330.1314 for

CisHiiNiOsNa.

(±)-Methyl 4-(carboxy-t-butyl)-anilno-3-oxo-5-phenylpentanoate (50d)
63%, white solid; mp = 78 - 79 °C: lH NMR (360 MHz, CDCI3 ) 8 7.33-7.16 (m, 5H),
5.02 (m, IH), 4.56 (dt, IH, 7=7.2,7.2Hz), 3.71 (s, 3H), 3.52 (d, IH, 7 = 16.0 Hz), 3.46 (d,
IH, 7 = 16.0 Hz), 3.14 (d, 1 ,7 = 14.0 Hz), 2.97 (d, IH, 7 = 14.0), 1.40 (s, 9H); 13C NMR
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(90 MHz, CDCI3 ) 8 201.8,167.3,155.2,136.0,129.2,128.7,127.0, 80.2,60.4, 52.4,
46.6.36.9.28.2. HRMS (M+H)+ calculated 322.1649, found 322.1668 for Ci7 H24 N l0 5.

Methyl 4-(carboxybenzyl)-aniino-3-oxo-butanoate (50e)
65%, yellow oil; lH NMR (360 MHz, CDCI3 ) 8 7.36 (m, 5H), 5.41 (bs, IH), 5.13 (s, 2H),
4.22 (d, 2H, 7 = 5.0 Hz), 3.75 (s, 3H), 3.51 (s, 2H); ,3C NMR (90 MHz, CDCI3 ) 8 198.3,
166.7.156.2, 136.2,128.5,128.2, 128.1,67.1, 52.6,50.8,46.2.

(±)-Methyl 4-(carboxybenzyl>aniino-3-oxo-pentanoate (501)
66

%, yellow oil; lH NMR (360 MHz, CDCI3 ) 8 7.39-7.26 (m, 5H), 5.72 (d, IH, 7 = 7.1

Hz), 5.08 (s, 2H), 4.40 (s, IH), 3.68 (s, 3H), 3.60-3.47 (m, 2H), 1.33 (d, 3H, 7 = 7.1 Hz);
l3C NMR (90 MHz, CDCI3 ) 5 202.0, 167.3, 155.8,136.2, 128.5,128.2, 128.0,67.0,55.8,
52.4,45.5, 16.8.

(±>Methyl 4-(carboxybenzyl)-amino-5-methyl-3-oxobexanoate (50g)
34%, colorless oil; lH NMR (360 MHz, CDC13) 8 7.37-7.30 (m, 5H), 5.36 (d, IH, 7 = 8.7
Hz), 5.12 (s, 2H), 4.42 (dd, IH, 7 = 3.9, 8.7 Hz), 3.71 (s, 3H), 3.55 (bs, IH), 2.27-2.20
(m, IH), 1.02 (d, 3H, 7 =
8

6 .8

Hz), 0.80 (d, 3H, 7 =

6 .8

Hz); I3C NMR (90 MHz, CDCI3 )

201.7,167.2,156.6, 136.6,128.7,128.4,128.3,67.4,65.0,52.6,47.1,29.8,20.0,16.7.

(±)-Methyl 4-(carboxybenzyl>amino-3-oxo-4-phenylbutanoate (50h)
45%, colorless oU; lH NMR (360 MHz, CDCI3 ) 8 7.38-7.26 (m, 10H), 6.14 (bs, IH), 5.52

43

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

(m, 1 H), 5.13-5.00 (m, 2H), 3.66 (s, 3H), 3.49 (d, IH, 7 = 12.1 Hz), 3.34 (d, IH, 7 =
12.0); l3C NMR (90 MHz, CDC13) 6 197.7, 166.5, 155.2, 136.0, 135.3, 129.4, 129.4,
129.0,128.5,128.1, 128.1,67.1,64.6,52.5,45.7. HRMS (M+Na)+ calculated 364.1155,
found 364.1171 for CigH^NiOsNa.

(±)-Methyl 4-<carboxybenzyl)-aniino-3-oxo-5-phenylpentanoate (500
71%, colorless oil; 'H NMR (360 MHz, CDClj) 8 7.39-7.23 (m, 8 H), 7.15 (m, 2H), 5.35
(d, IH, 7 = 7.7 Hz), 5.12 (s, 2H), 4.67 (dd, IH, 7 = 7.0,13.8 Hz), 3.70 (s, 3H), 3.55-3.43
(AB, 2 H ,7 = 16 Hz), 3.17 (dd, 1 H ,7 = 6 .1 ,14.1 Hz), 3.01 (dd, 1 H ,7 = 6 .0 ,14.1 Hz); l3C
NMR (90 MHz, CDCI3 ) 8 201.6,167.3, 155.8,136.2, 135.8,129.2, 128.8, 128.5,128.2,
128.1,127.2,67.1,60.8, 52.4,46.7,36.9. HRMS (M+Na)+ calculated 378.1312, found
378.1305 forC 20 H 2 ,NiOsNa.

Methyl 4-(N-benzoyl)-aniino-3-oxo-butanoate (50j)
65%, Ideal solvent for flash chromatography is 30% acetone in hexane. White solid; mp =
83 -

86

°C: 'H NMR (360 MHz, CDClj) 8 7.83 (m, 2H), 7.55-7.43 (m, 3H), 6.93 (bs,

IH), 4.47 (d, 2H, 7 = 4.7 Hz), 3.76 (s, 3H), 3.59 (s, 2H); I3C NMR (90 MHz, CDClj)
8

198.1, 167.3,166.9,133.5,131.9,128.6,127.1,52.6,49.9,46.5.

(±)-Methyl 4-(N-benzoyI>amino-3-oxo-pentanoate (501t)
47%, colorless oil; lH NMR (360 MHz, CDCI3 ) 8 7.80-7.76 (m, 2H), 7.52-7.38 (m, 3H),
7.11 (d, IH, 7 = 6.5 Hz), 4.85 (m, IH), 3.70 (s, 3H), 3.66 (d, IH, 7 = 15.6 Hz), 3.60 (d,
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IH, J = 15.0 Hz), 1.41 (d, 3H, J = 7.3 Hz); l3C NMR (90 MHz, CDC13) 8 201.9, 167.3,
166.9.133.5, 131.8,128.6, 127.0, 54.7,52.5,45.7,16.8.

(±)-Methyl 4-(N-benzoyl)-ainino-3-oxo-4-phenylbutanoate (501)
28%, colorless oil; lH NMR (360 MHz, CDCI3 ) 8 7.81 (bs, IH), 7.52-7.33 (m, 10H), 5.90
(d, IH, 7 = 6.1Hz), 3.67 (s, 3H), 3.53 (d, IH, 7 = 15.4 Hz), 3.43 (d, IH, 7 = 15.4 Hz); l3C
NM R(90MHz,CDCl3) 8 198.3, 166.5,166.3, 135.3,133.5,131.8, 129.4, 129.0, 128.5,
128.3.127.1.63.5, 52.5,45.9. HRMS (M+H)+ calculated 334.1046, found 334.1050 for
C 18H 18 N 1O4 .

(±)-Methyl 4-(N-benzoyl)-ainlno-3-oxo-5-phenylpentanoate (50m)
74%, colorless oil; lH NMR (360 MHz, CDCh) 8 7.69 (m, 2H), 7.51 (m, IH), 7.39 (m,
2H), 7.32-7.19 (m, 5H), 6.87 (d, IH, 7 = 7.2 Hz), 5.10 (dt, IH, 7 = 6.9,7.2 Hz), 3.69 (s,
3H), 3.60 (d, IH, 7 = 15.8 Hz), 3.52 (d, IH, 7 = 15.7), 3.28 (dd, IH, 7 = 6.4,14.1 Hz),
3.16 (dd, 1H, 7 = 6 .3 ,1 4 .0 Hz); 13C N M R (90MHz,CDC13) 8 201.2, 167.2, 167.1,135.8,
133.4, 131.9,129.2, 128.8, 128.6, 127.2,127.0,59.6,52.4,46.8, 36.6. HRMS (M+Na)+
calculated 348.1206, found 348.1211 for Ci9 Hl9 N 10 4 Na.

Methyl 4-(carboxy-9-fluorenylmethyl>amino-3-oxo-butanoate (50n)
65%, white soUd; mp = 11 5 -1 1 7 °C: lH NMR (360 MHz, CDCI3 ) 8 7.77 (m, 2H), 7.59
(m, 2H), 7.42-7.29 (m, 4H), 5.63 (m, IH), 4.44 (m, 2H), 4.21 (m, 3H), 3.73 (s, 3H), 3.49
(s, 2H); I3C NMR (90 MHz, CDCI3 ) 8 198.3,167.1,156^, 143.7,141.3,127.7,127.1,
125.0,120.0,67.1,52.6,50.8,47.1,46.2.
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(±)-Methyl 4-(carboxy-9-fluorenylmethyI)-amino-3-oxo-peiitanoate (SOo)
76%, white solid; mp = 105 -1 0 7 °C: 'H NMR (360 MHz, C D C l3) 8 7.77 (m, 2H), 7.59
(m, 2H), 7.42-7.29 (m, 4H), 5.52 (bs, IH), 4.48-4.38 (m, 3H), 4.23-4.19 (m, IH), 3.73 (s,
3H), 3.55 (m, 2H), 1.39 (d, 3H, 7 = 7.0 Hz); l3C NMR (90 MHz, CDCI3) 8 202.1,167.0,
155.8, 143.7,141.3,127.7, 127.1, 125.0,120.0,66.9, 55.8,52.5,47.1,45.5, 17.0.

(±)-Methyl 4-(carboxy-9-fluorenylmethyl)-ainino-3-oxo-4-phenylbatanoate (50p)
85%, white solid mp. 139 - 142 °C: lH NMR (360 MHz, CDCI3) 8 7.77-7.75 (m, 2H),
7.58-7.56 (m, 2H), 7.42-7.26 (m, 9H), 6.16 (d, IH, J = 5.7 Hz), 5.54 (d, IH, J= 6.3 Hz),
4.42-4.30 (m, 2H), 4.21-4.18 (m, IH), 3.68 (s, 3H), 3.52 (d, IH, J = 16.0 Hz), 3.46 (d,
1H ,7= 16.0 Hz); 13C NMR (90 MHz, CDCI3) 8 197.8, 166.4,155.2, 143.8, 141.2, 135.3,
129.4,129.1, 128.1, 127.7,127.0,125.0, 119.9,67.1,64.6,52.5,47.1,45.7.

(±)-Methyl 4-(carboxy-9-fluorenylmethyl)-aiiiiiio-3-oxo-5-phenylpentanoate (50q)
67%, white solid; mp = 75 - 78 °C: 'H NMR (360 MHz, CDC13) 8 7.78 (m, 2H), 7.55 (m,
2H), 7.42 (m, 2H), 7.31-7.24 (m, 5H), 7.16 (m, 2H), 5.48 (d, IH, J = 7.8 Hz), 4.67 (dt,
IH, J = 7.6, 7.8 Hz), 4.46-4.38 (m, 2H), 4.20-4.15 (m, IH), 3.71 (s, 3H), 3.52 (d, IH, J=
16.0 Hz), 3.46 (d, IH, J = 16.0 Hz), 3.19 (A o f AB, IH, J= 6.0,14.0 Hz), 3.00 (B o f AB,
IH, / = 7.5,14.0 Hz); 13C NMR (90 MHz, CDCI3) 8 201.4,167.2,155.8,143.7,141.3,
135.9,129.3,128.8,127.8,127.2,127.1,125.0,120.0,66.9,60.8,52.5,47.2,46.6,36.7.
HRMS (M + H f calculated 466.1625, found 466.1617 for C ^ H ^ O s N a .
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Formation o f the (J-Keto Benzyl Ester (Masamune-Brooks procedure using
monobenzyl malonate)

Monobenzyl Malonate
Into a 2S0 mL round-bottomed flask was added 25 g (173 mmol) 2,2-dimethyl-1,3dioxane-4,6-dione, 35 mL (337 mmol) benzyl alcohol, and 100 mL toluene. The reaction
was heated for 24 h at 106 °C before it was concentrated to approximately one half of its
initial volume on the rotary evaporator. The concentrated mixture was partitioned
between 200 mL Et20 and 350 mL 5% Na2 C0 3 and the aqueous portion washed twice
more with 100 mL Et2 O. The aqueous layer was then acidified to pH - 2 with 1M HC1
and then extracted with 3 X 150 mL EtOAc. The combined EtOAc extracts were dried
with MgS0 4 and concentrated to a viscous oil which was pumped for 2 h at high vacuum.
Crystallization of the oil was affected by the addition o f a small amount of dry THF and
the resultant material pumped for 2 h to remove any further moisture or solvent to yield
17.5 g (52%) pure monobenzyl malonate as a white solid; lH NMR (360 MHz, CDCI3 )
8

7.43-7.32 (m, 5H), 5.22 (s, 2H), 3.49 (s, 2H).

Benzyl (4S)-4-(carboxy-t-butyl)-amino-3-oxo-p*nUnoate (55b)
Boc-L-alanine L-48b (176 mg, 0.93 mmol) was dissolved in 10 mL anhydrous THF in a
25 mL round-bottomed flask and 154 mg (0.95 mmol) of CDI added while stirring, hi a
separate 100 mL flask monobenzyl malonate (722 mg, 3.72 mmol) was dissolved in 30
mL anhydrous THF and 1.86 mL (1.86 mmol) o f a 1M solution of dibutylmagnesium was
added at 0 °C. The reaction was allowed to warm to room temperature (solution is
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colorless and clear). After gas evolution was complete (IS min), the acyl imidazole was
transferred to the magnesium malonate solution. The reaction was monitored by TLC and
quenched after 24h by addition o f 30 mL sat aq. NH4 CI solution. The solution was
extracted three times with 20 mL Et2 0 and the combined organic layers were dried with
MgS04, filtered, and concentrated. The residue was chromatographed on silica with 15%
EtOAc in hexanes to yield 208 mg (70%) 55b as a colorless oil: 'H NMR (360 MHz,
CDClj) 6 7.38-7.31 (m, 5H), 5.18 (s, 2H), 5.08 (s, IH), 4.36 (m, IH), 3.66-3.56 (m, 2H),
1.44 (s, 9H), 1.33 (d, 3H, J = 7.1 Hz); l3C NMR (90 MHz, CDClj) 8 202.4,166.4,155.5,
135.0,128.6,128.4,128.3, 79.8,67.2, 55.4,45.7,28.2,16.8. HRMS (M+Na)+ calculated
344.1468, found 344.1464 forCnH^NiOs.

Benzyl (4S)-4-[(tei1-butoxycarbonyI)amino]-3-oxo-4-plienylbutanoate (55c)
71%, colorless oil: ‘H NMR (360 MHz, CDClj) 8 7.39-7.27 (m, 10H), 5.82 (s, IH), 5.45
(d, l H , / = 5.9 Hz), 5.19 (m, IH), 5.10 (s, IH), 3.52 (d, I H ,J = 15.8 Hz), 3.39 (d, 1H ,7=
15.8 Hz), 1.41 (s, 9H); l3C NMR (90 MHz, CDClj) 8 198.1,166.1, 154.5,135.8,135.0,
129.3,128.8,128.5,128.3, 128.1, 128.0,80.2,67.2,64.4,45.9,28.2.

Benzyl (4S)-4-[(tert-butoxycarbonyl)amino]-3-oxo-5-phenylpentanoate (55d)
82%, colorless oil: lH NMR (360 MHz, CDClj) 8 7.42-7.13 (m, 10H), 5.16 (m, 2H), 4.97
(d, IH, J = 6.5 Hz), 4.55 (dt, IH, J= 7.0,7.0 Hz), 3.56 (d, IH, J= 16.1 Hz), 3.49 (d, IH,

J = 16.0 Hz), 3.14 (dd, IH, J = 5.9,13.9 Hz), 2.95 (dd, IH, J= 5.8,13.8 Hz), 1.39 (s,
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9H); I3C NMR (90 MHz, CDCI3 ) 8 201.8,166.7,155.2,136.0,135.2,129.2,128.7,
128.6,128.5,128.4,127.0,80.2,67.2,60.5,46.8,36.9,28.2.

Dibenzyl (3S)-3-[(tert-butoxycarbonyI)amino]-4-oxohexanedioate (55r)
74%, colorless oil: lH NMR (360 MHz, CDCI3 ) 6 7.39-7.33 (m, 10H), 5.60 (d, IH, 7 =
8.9 Hz), 5.17 (m, 2H), 5.11 (s, 2H), 4.59 (m, IH), 3.68 (s, 2H), 3.04 (dd, IH, 7 = 5.0,17.4
Hz), 2.81 (dd, IH, 7 = 5.2,18.0 Hz), 1.45 (s, 9H); 13C NM R(90 MHz, CDC13) 8 201.4,
171.3,166.4, 155.5, 135.2, 135.2, 128.6, 128.6,128.4, 128.4, 128.2, 128.2,80.8,67.2,
66.9, 56.0,45.8,35.3,28.2.

Benzyl (4S)-4,8-bis[(tert-butoxycarbonyI)amino]-3-oxooctanoate (55u)
57%, colorless oil: *H NMR (360 MHz, CDCI3 ) 8 7.37 (m, 5H), 5.16-5.20 (m, 2H), 4.56
(bs, IH), 4.30 (m, IH), 3.64 (d, IH, 7 = 16.0 Hz), 3.57 (d, IH, 7 = 15.8 Hz), 3.08 (m, 2H),
1.84 (m, 2H), 1.60-1.28 (m, 6 H), 1.44 (s, 18H); ,3C NMR (90 MHz, CDCI3 ) 8 207.8,
166.7, 156.2, 155.8, 135.3, 128.6, 128.5,128.4,80.1,79.5,67.2, 59.5,46.1,39.7,30.3,
29.6,28.4,28.3,22.2.

Benzyl (4S)-5-(benzyloxy)-4-[(tert-batoxycarbonyI)amlno]-3-oxopentanoate (55w)
75%, colorless oil: lH NMR (360 MHz, CDCb) 8 7.41-7.25 (m, 10H), 5.50 (d, IH, 7 =
7.2 Hz), 5.16 (s, 2H), 4.47 (m, 2H), 3.90 (m, IH), 3.65 (m, 2H), 1.45 (s, 9H); 13C NMR
(90 MHz, CDCI3 ) 8 200.4, 166.6,155.5,137.0, 135.5,128.6, 128.5, 128.3, 127.9,127.7,
80.5,73.4,69.3,67.1,59.8,46.7,28.3.
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ferf-Butyl (lS)-l-benzyl-2-oxopropylcarbamate (57d)
'H NMR (360 MHz, CDC13) 6 7.38-7.15 (m, 5H), 5.54 (m, IH), 5.11 (m, IH), 3.13-2.96
(m, 2H), 2.13 (s, 3H), 1.42 (s, 9H).

3-{[(lS)-l-Beiizyl-2-methoxy-2-oxoethyl]aiiiino}-3-oxopropanoic acid (58)
Into a 25 mL round bottom flask charged with 10 mL absolute ethanol and 400 mg (1.12
mmol) 63 is added 20 mg o f 10 wt% palladium on activated carbon. The flask is charged
twice with nitrogen and twice with hydrogen and kept under a hydrogen atmosphere
while monitoring by TLC until complete (3h). The flask is flushed with nitrogen and the
reaction Altered through a 0.45 uM syringe Alter before concentrating to yield 248 mg
(83%) 58; lH NMR (360 MHz, CDCI3) 6 7.55 (m, IH), 7.28-7.09 (m, 5H), 4.85 (q, IH, J
= 6.5,13.4 Hz), 3.70 (s, 3H), 3.31 (s, 2H), 3.15 (dd, IH, J = 5.7,13.9 Hz), 3.09 (dd, IH, J
= 5.8,14.0 Hz); I3C NMR (90 MHz, CDCI3) 8 171.7, 170.0, 167.4,135.5,129.2, 128.6,
127.2, 53.7,52.5,39.3,37.6.

Methyl N-[3-(benzyloxy)-3-oxopropanoyl]-L-phenyIaIaninate (63)
Into a 50 mL round-bottomed flask charged with 20 mL toluene was added 1.46 g (7.54
mmol) monobenzyl malonate and 5 mL oxalyl chloride. The mixture was stirred
overnight and then concentrated to give 1.60 g of monobenzyl malonyl chloride as a
viscous yellow oil. The acid chloride was dissolved in 10 mL CH 2 CI2 and added to a
solution o f 1.62 g (7.54 mmol) L-phenylalanine methyl ester hydrochloride in 40 mL
CH2 CI2 and the solution cooled to 0 °C before adding 1.00 mL triethylamine slowly
dropwise. The reaction was stirred for 15 minutes and then diluted with 50 mL CH2 CI2
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before washing with SO mL sat aq. NH4CI, SO mL sat N aH C 03 and 30 mL H 2 O. The
organic portion was dried with MgSO< and concentrated under reduced pressure. Flash
chromatography on silica using 30% EtOAc in hexanes yielded 1.82 g (70 %) 63; lH
NMR (360 MHz, CDCI3) 8 7.38-7.24 (m, iOH), 7.11 (m, IH), 5.16 (s, 2H), 4.88 (dd, IH,

J= 5.9,13.6 Hz), 3.72 (s, 3H), 3.35 (s, 2H), 3.15 (dd, IH, J = 6.1,14.2 Hz), 3.09 (dd, IH,
7 = 6 .0 , 14.2 Hz); I3C NMR (90 MHz, CDCI3) 5 170.3,166.9, 166.7, 137.8,135.4,

129.4, 128.7,128.4, 127.8,127.2, 126.7,62.2, 53.0, 52.2,41.5.

Methyl N-benzyl-L-phenylalaniDate (64)
Into a 100 mL round-bottomed flask was added 1.23 g (6.87 mmol) L-phenylalanine
methyl ester 61 and the flask charged with 35 mL anhydrous DMF. The flask was cooled
to 0 °C and 274 mg (6.87 mmol) of a 60% dispersion of NaH in mineral oil added in
small portions. After stirring vigorously for 10 min, benzyl bromide (763 uL, 6.18 mmol)
was added slowly dropwise and the reaction monitored by TLC until complete (<15
minutes). The reaction was diluted with 40 mL sat aq. NH4 CI solution and 50 mL Et2 0
and the organic layer was separated and washed with 2 x 20 mL H 2 O. The organic
portion was dried with MgS( > 4 and concentrated under reduced pressure. Flash
chromatography on silica using 20% EtOAc in hexanes yielded 1.30 g (70 %) methyl Nbenzyl-L-phenylalaninate 64 as a colorless oil. 'H NMR (360 MHz, CDCI3 ) 8 7.35-7.12
(m, 10H), 3.80 (d, IH, .M 3 .2 Hz), 3.65 (s, 3H), 3.64 (d, IH, / = 13.0 Hz), 3.55 (m, IH),
2.94 (d, 2H, J = 13.5 Hz); l3C NMR (90 MHz, CDCI3 ) 8 175.0, 139.5,137.3,129.2,
128.3,128.2,128.1,127.0,126.6,62.0,51.9,51.6,39.7.
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Methyl N-benzyl-N-[3-(benzyloxy)-3-oxopropanoyI]-L-plienylalaninate (65)
Into a 25 mL round-bottomed flask charged with 10 mL toluene was added 440 mg (2.23
mmol) monobenzyl malonate and 2 mL oxalyl chloride. The mixture was stirred
overnight and then concentrated to give 480 mg of monobenzyl malonyl chloride as a
viscous yellow oil. The acid chloride was dissolved in 5 mL CH2 CI2 and added to a
solution o f 610 mg (2.23 mmol) methyl N-benzyl-L-phenylalaninate in

10

mL CH 2 CI2 .

The solution is cooled to 0 °C and triethylamine (300 uL, 2.23 mmol) is added slowly
dropwise. The reaction was stirred for 15 minutes and then diluted with 30 mL CH 2 CI2
before washing with 30 mL sat. aq. NH4 CI, 30 mL sat. NaHC0 3 and 30 mL H2 O. The
organic portion was dried with MgS0 4 and concentrated under reduced pressure. Flash
chromatography on silica using 20% EtOAc in hexanes yielded 600 mg (75 %) methyl Nbenzyl-N-[3-(benzyloxy)-3-oxopropanoyl]-L-phenylalaninate 65 as a colorless oil; ‘H
NMR (360 MHz, CDC13) 6 7.38-7.05 (m, 15H), 5.19 (s, 2H), 4.42 (1H, A of AB, J= 17.0
Hz), 4.33 (dd, IH , J = 5.8,9.1 Hz), 3.85 (IH, B of A B ,J = 16.9 Hz), 3.62 (s, 3H), 3.513.25 (m, 3H), 3.22-3.18 (m, IH); l3C NMR (90 MHz, CDC13) 8 170.3,166.9, 166.7,
137.8,135.4,129.4,129.2, 128.7,128.6, 128.4, 127.8,127.2, 126.7,67.2,61.4, 52.9,
52.1,41.5,35.1.

3-{Benzyl[(lS)-l-benzyl-2-methoxy-2-oxoethyl]ainino}-3-oxopropanoic acid (66)
Into a 25 mL round-bottomed flask containing 360 mg (1.10 mmol) methyl N-benzyl-N[3-(benzyloxy)-3-oxopropanoyl]-L-phenylalaninate 65 and charged with 5 mL absolute
ethanol was added 300 mg o f 10 wt% palladium on activated carbon and 960 ul (11.00
mol) 1 ,4-cyclohexadiene. The solution was stirred 3h and filtered through a 0.45 uM
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syringe filter before concentrating and chromatographing on silica using 8 S/1 S CH2 CI2 /10% NH4 OH in MeOH to yield 240 mg (85%) 3-{benzyl[( 1S> 1-benzyl-2-mcthoxy-2oxoethyl]amino}-3-oxopropanoic acid 6 6 as a white solid; 'H NMR (360 MHz, CDCI3 )
8

7.27-7.06 (m, 10H), 5.70 (s, IH), 4.47 (1H, A of AB, J= 16.7 Hz), 4.30 (m, IH), 3.87

(IH, B o f AB, J = 16.5 Hz), 3.60 (s, 3H), 3.39-3.20 (m, 3H), 3.20-3.14 (m, IH); 13C
NMR (90 MHz, CDCI3) 8 171.0,169.8, 167.5,137.2, 133.9,129.0, 128.9,128.8, 128.3,
127.1,127.0,62.1, 52.6, 52.6,36.2,34.9.

Zinc-mediated Chain Extension Reaction General Experimental Procedure Methyl Esters

Methyl 5-(carbobenzyloxy)amino-4-oxo-6-phenyl-hexanoate (741)
A 50 mL round-bottomed flask was charged with 30 mL anhydrous CH2 CI2 and 255 uL
(3.16 mmol) o f methylene iodide added. The solution was cooled to 0 °C and 2.11 mL
(2.11 mmol) of a 1M solution of diethylzinc in hexanes was added slowly. The ice bath
was removed immediately and a white precipitate formed rapidly. After stirring for two
minutes, a 5 mL CH 2 CI2 solution of 150 mg (0.42 mmol) 50i was added and the reaction
monitored by TLC (normal phase). The product spot appeared at a slightly higher R/
than starting material and was best visualized by staining the TLC plates with
anisaldehyde. The reaction was complete after 30 min and was quenched with 25 mL sat
aq. NH4 CI solution. The organic solution was dried with MgS(>4 , filtered, and evaporated
under reduced pressure. Flash chromatography on silica using 15 % EtOAc in hexane
provided 106 mg (6 8 %) of 74i as a colorless oil: lH NMR (360 MHz, CDCI3 ) 8 7.38-7.14
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(1X1, 10H), 5.38 (d, 1H, J= 7.3 Hz), 5.08 (s, 2H), 4.64 (dd, IH, J=

6 .6

Hz), 3.67 (s, 3H),

3.16 (dd, IH, J = 6.4,14.1), 2.99 (dd, IH, J = 6.9,14.1), 2.81-2.74 (m, 2H), 2.60-2.57 (m,
2H); l3C NMR (90 MHz, CDC13) 8 207.0, 173.0,156.0,136.2, 135.9, 129.2, 128.7,
128.5, 128.2,128.1, 127.1,66.9,60.5,51.8,37.4,35.1,27.5. HRMS (M +Naf calculated
392.1468, found 392.1477 for C2 iH23 N 10 5 Na.

Zinc-mediated Chain Extension Reaction General Experimental Procedure - Benzyl
Esters

Phenylmethyl (5S)-5-(carboxy-t-butyl)-amino-4-oxo-hexanoate (75b)
A 50 mL round-bottomed flask was charged with 30 mL anhydrous CH2 CI2 and 375 uL
(4.67 mmol) methylene iodide and cooled to 0 °C. A1M solution o f diethylzinc in
hexanes (3.11 mL, 3.11 mmol) was added slowly. The ice bath was removed and a white
precipitate formed rapidly. After stirring 2 min, 200 mg (0.62 mmol) o f 55b dissolved in
5 mL CH2 CI2 was added and the reaction monitored by TLC. The product spot appeared
at a slightly higher R/ than starting material and was best visualized by staining the TLC
plates with anisaldehyde. The reaction was complete after 30 min and was washed with
25 mL sat. aq. NH4 CI solution before drying with MgS0 4 and concentrating. Flash
chromatography on silica using 15 % EtOAc in hexane yielded 164 mg (79 %) of 75b as
a colorless oil: ‘H NMR (360 MHz, CDC13) 8 7.39-7.29 (m, 5H), 5.18 (m, IH), 5.11 (s,
2H), 4.33 (m, IH), 2.92-2.62 (m, 4H), 1.44 (s, 9H), 1.33 (d, 3H, J = 7.1 Hz); l3C NMR
(90 MHz, CDCI3 ) 8 207.9, 172.3, 155.5,135.7,128.5, 128.3,128.2, 79.8,66.5,55.0,
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33.6,28.3,27.8, 17.6. HRMS (M+Na)+ calculated 358.1625, found 358.1599 for

CigHyNiOsNa.

Methyl 5-(carboxy-t-butyl)-amino-4-oxo-pentanoate (74a)
(reaction time 5 minutes) 25%, colorless oil; 'H NMR S (360 MHz, CDCh) 5.21 (bs,
IH), 4.06 (m, 2H), 3.67 (s, 3H), 2.74-2.62 (m, 4H), 1.43 (s, 9H); l3C NMR (90 MHz,
CDCI3)

6

204.2,172.8,155.6,79.8,51.8,50.2,34.3,28.2,27.5.

(±)-Methyl 5-(carboxy-t-butyl)-amino-4-oxo-hexanoate (74b)
48%, colorless oil; lH NMR (360 MHz, CDCI3) S 5.21 (bs, IH), 4.34 (dt, IH, 7 = 6.2,6.2
Hz), 3.68 (s, 3H), 2.91-2.56 (m, 4H), 1.44 (s, 9H), 1.36 (d, 3H, 7 = 6.2 Hz); l3C NMR (90
MHz, CDCh) 6 207.8, 173.2, 155.1, 79.9,55.0, 51.8.33.6,28.3,27.5,17.7.

(±)-Methyl 5-(carboxy-t-butyl)-amino-4-oxo-5-phenylpentanoate (74c)
57%, colorless oil; ‘H NMR (360 MHz, CDCI3 ) 5 7.40-7.30 (m, 5H), 5.86 (bs, IH), 5.33
(d, IH, 7 = 5.4 Hz), 3.65 (s, 3H), 2.81-2.46 (m, 4H), 1.40 (s, 9H); l3C NMR (90 MHz,
CDCI3)

6

204.3, 172.6, 154.8,136.8, 129.1,128.5, 127.8,79.9,64.1,51.8,34.3,28.2,

27.6. HRMS (M +N af calculated 322.1648, found 322.1655 for C n H ^ O s N a .

(±)-Methyl 5-(carboxy-t-butyl)-ainino-4-oxo-6-phenylhexanoate (74d)
49%, colorless oil; lH NMR (360 MHz, CDC13) 6 7.33-7.25 (m, 4H), 7.19 (m, IH), 5.05
(bs, IH), 4.54 (m, IH), 3.68 (s, 3H), 3.16-3.10 (AX, IH, 7 = 7.1,14.0 Hz), 2.98-2.93
(BX, IH, 7 = 7.0,13.9 Hz), 2.78-2.69 (m, 2H), 2.60-2.56 (m, 2H), 1.40 (s, 9H); 13C NMR
55
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(90 MHz, CDCI3 ) 8 207.4, 172.9,155.1,136.2, 129.2, 128.6,126.9, 80.0,60.1, 51.8,
37.5,35.1,28.2,27.5. HRMS (M+Na)+ calculated 358.1625, found 358.1635 for

CigHyNjOsNa.

Methyl 5-(carboxybenzyl>-amino-4-oxo-pentanoate (74e)
60%, colorless oil; lH NMR (360 MHz, CDCI3) 8 7.36-7.30 (m, 5H), 5.46 (bs, IH), 5.12
(s, 2H), 4.16 (m, 2H), 3.68 (s, 3H), 2.75-2.68 (m, 4H); ,3C NMR (90 MHz, CDCI3)
8

203.7,172.8, 156.1,136.2, 128.5,128.1, 128.0,67.0,51.9, 50.6,34.3,27.5.

(±>Methyl 5-(carboxybenzyl)-amino-4-oxo-hexanoate (74f)
60%, colorless oil; ‘H NMR (360 MHz, CDC13) 8 7.41-7.30 (m, 5H), 5.51 (bs, IH), 5.11
(s, 2H), 4.43 (m, IH), 3.68 (s, 3H), 2.94-2.59 (m, 4H), 1.41 (d, 3H, J= 7.1 Hz); I3C NMR
(90 MHz, CDCI3 ) 8 207.6,172.9,155.7,136.0, 128.5,128.1, 128.0,66.9,55.5, 51.8,
33.6, 27.5, 17.6.

(±)-Methyl 5-(carboxybenzyl)-ainino-6-methyl-4-oxobeptanoate (74g)
77%, colorless oil; *H NMR (360 MHz, CDCI3 ) 8 7.34-7.240 (m, 5H), 5.35 (d, IH, J=
8.4 Hz)), 5.07 (s, 2H), 4.36 (dd, IH, J = 3.8,8.4 Hz)), 3.65 (s, 3H), 2.92-2.52 (m, 4H),
2.27-2.20 (m, IH), 1.01 (d ,3 H ,J= 6 .7 H z),0 .7 8 (d ,3 H ,J= 6 .7 H z); l3C NMR (90 MHz,
CDCI3 ) 8 207.5,173.0,156.7,136.4,128.7,128.4,128.3,67.2,64.6,52.0,35.6,30.5,
27.6,20.0,16.7.
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(±>Methyl 5-(carboxybenzyl)-amino-4-oxo-5-phenylpentanoate (74h)
48%, colorless oil; lH NMR (360 MHz, CDCh) 8 7.40-7.33 (m, 10H), 6.16 (bs, IH), 5.39
(d, IH, J= 6.1 Hz), 5.10 (d, IH, J = 12.2 Hz), 5.01 (d, IH, J= 12.1 Hz), 3.67 (s, 3H),
2.73-2.51 (m, 4H); l3C NMR (90 MHz, CDCI3 ) 8 204.0, 172.5, 155.5, 136.5, 136.2,
133.1,129.2, 128.7,128.5, 128.1, 127.9,66.9,64.5,51.8,34.3,27.6. HRMS (M +H f
calculated 356.1492, found 356.1491 for C2 0 H 21 N 1O5 .

(±)-Methyl 5-(carboxybenzyl>amino-4-oxo-6-phenylhexanoate (741)
68

%, colorless oil; 'H NMR (360 MHz, CDC13) 8 7.38-7.14 (m, 10H), 5.38 (d, IH, J=

7.3 Hz), 5.08 (s, 2H), 4.64 (q, IH, J= 7.3 Hz), 3.67 (s, 3H), 3.16 (dd (A of AB), IH, J=
6.4,14.1), 2.99 (dd (B of AB), IH, J= 6.9,14.1), 2.81-2.74 (m, 2H). 2.60-2.57 (m, 2H);
13C NMR (90 MHz, CDCI3 ) 8 207.0, 173.0, 156.0, 136.2, 135.9, 129.2, 128.7, 128.5,
128.2,128.1,127.1,66.9,60.5,51.8,37.4,35.1,27.5. HRMS (M +Naf calculated
392.1468, found 392.1472 forC2iH23N,05Na.

Methyl 5-(N-benzoyl)-amino-4-oxo-pentanoate (74j)
58%, colorless oil; lH NMR (360 MHz, CDCI3 ) 8 7.83-77.5 (m, 2H), 7.55-7.41 (m, 3H),
6.93 (bs, IH), 4.42 (d, 2H, J= 4.5 Hz), 3.70 (s, 3H), 2.88-2.70 (m, 4H); 13C NMR (90
MHz, CDCI3 ) 8 203.9, 172.8,167.2, 133.7, 131.7, 128.6,127.0,51.9,49.6,34.6,27.6.

(±)-Methyl 5-(N-benzoyl)-amino-4-oxo-hexanoate (74k)
58%, colorless oil; lH NMR (360 MHz, CDCI3 ) 8 7.82-7.79 (m, 2H), 7.53-7.42 (m, 3H),
7.02 (d, IH, J= 6.3 Hz), 4.85 (dq, IH, J= 7.0,7.0 Hz), 3.68 (s, 3H), 3.01-2.61 (m, 4H),
57
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1.52 (d, 3H, J = 7.1 Hz); 13C NMR (90 MHz, CDC13) 8 207.9, 173.0,166.6, 134.0,131.7,
128.5, 127.0,54.4, 51.9,33.8,27.6,17.6.

(±)-Methyl 5-(N-benzoyl)-aiiiino-4-oxo-5-plienylpenUnoate (740
43%, colorless oil; 'H NMR (360 MHz, CDClj) 8 7.81 (m, 1H), 7.55-7.33 (m, 9H), 5.79
(d, IH, J =6.1 Hz), 3.65 (s, 3H), 2.90-2.50 (m, 4H); l3C NMR (90 MHz, CDCI3) 8
204.6, 172.8, 166.5, 136.5, 133.9, 131.7,129.3, 128.7,128.5, 128.1, 127.1,63.3, 52.0,
34.5,27.7. HRMS (M+Na)+ calculated 348.1206, found 348.1199 for Cl9 Hi9 N 10 4 Na.

(±)-Methyl 5-(N-benzoyl)-aniino-4-oxo-6-phenylhexanoate (74m)
58%, colorless oil; lH NMR (360 MHz, CDCI3 ) 8 7.72 (m, 2H), 7.51-7.20 (m, 8 H), 6.77
(d, 1H, J = 6 . 8 Hz), 5.07 (dt, 1H, J= 6 .6 , 6 . 6 Hz), 3.68 (s, 3H), 3.30 (dd, 1H / = 6.7,14.1
Hz), 3.17 (dd, 1H, J= 6.5,14.3 Hz), 2.83 (dd, 2H, J= 5.0,5.1 Hz), 2.62 (dd, 2H, J = 5.1.
5.0 Hz)); 13C NMR (90 MHz, CDCI3 ) 8 206.8,173.2, 166.8,136.0, 133.9, 131.8, 129.3,
128.7.128.6, 127.1,126.9,59.3,51.9,37.2,35.2,27.6. HRMS (M+Na)+ calculated
362.1363, found 362.1364 for C2 oH2 iN,0 4 Na.

Methyl 5-(carboxy-9-fluorenylinethyl)-amino-4-oxo-pentanoate (74n)
55%, white sohd; mp = 75 - 78 °C: lH NMR (360 MHz, CDCI3) 8 7.75 (m, 2H), 7.60 (m,
2H), 7.42-7.29 (m, 4H), 5.56 (bs, 1H), 4.40 (m, 2H), 4.27 (m, 1H), 4.15 (m, 2H), 3.68 (s,
3H), 2.73-2.66 (m, 4H); 13C NMR (90 MHz, CDCI3) 8 204.0,172.8,156.2,143.9,141.3,
127.7,127.0,125.1,119.9,67.1, 52.2,50.6,47.1,34.3,27.5.
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(±)-Methyl 5-(carboxy-9-fluorenylmethyI)-amino-4-oxo-hexanoate (74o)
57%, white solid; mp = 95 - 97 °C: lH NMR (360 MHz, CDCI3 ) 5 7.77 (m, 2H), 7.60 (m,
2H), 7.42-7.30 (m, 4H), 5.56 (bs, 1H), 4.45-4.35 (m, 3H), 4.22 (m, 1H), 3.68 (s, 3H),
2.92-2.59 (m, 4H), 1.42 (d, 3H, 7 = 7.1 Hz); UC NMR (90 MHz, CDC13) 8 207.7,173.0,
155.8.144.0, 141.3,127.7, 127.0, 125.0, 120.0,66.8,55.5,51.9,47.1,33.7,27.5, 17.8.

(±)-MethyI 5-(carboxy-9-fluorenylmethyl)-aiiiino-4-oxo-5-phenylpentanoate (74p)
63%, white solid; mp = 110 -1 1 5 °C: lH NMR (360 MHz, CDCI3 ) 8 7.76 (m, 2H), 7.56
(m, 2H), 7.41-7.21 (m, 9H), 6.21 (m, 1H), 5.41 (m, 1H), 4.40-4.29 (m, 2H), 4.21-4.17 (m,
1H), 3.64 (s, 3H), 2.81-2.48 (m, 4H); l3C NMR (90 MHz, CDCI3 ) 8 204.0, 172.5, 155.8,
143.8,141.2,136.3,129.3,128.8, 127.9,127.6,127.0,125.0,119.9,67.0,64.5,51.9,
47.1,34.3,27.2.

(±)-Methyl 5-(carboxy-9-flaorenylmethyl)-ainino-4-oxo-6-pheDylhexanoate (74q)
68

%, white solid; mp = 1 0 8 -1 1 0 °C: lH NMR (360 MHz, CDCI3) 8 7.78 (m, 2H), 7.55

(m, 2H), 7.42 (m, 2H), 7.31-7.24 (m, 5H), 7.16 (m, 2H), 5.48 (d, 1H, 7 = 7.8 Hz), 4.67
(dt, IH, 7 = 7.6, 7.8 Hz), 4.43-4.33 (m, 2H), 4.21-4.17 (m, 1H), 3.68 (s, 3H), 3.19 (d, 1H,
7 = 6.0,14.0 Hz), 3.00 (d, 1H, 7 = 7.5,14.0 Hz), 2.79-2.74 (m, 2H), 2.64-2.60 (M, 2H);
l3C NMR (90 MHz, CDCI3) 8 206.8, 173.0,155.8, 143.7, 141.3,136.0, 129.2, 128.7,
127.7.127.1.127.0.125.0.120.0.66.9.60.5.51.9.47.1.37.3, 35.0,27.5. HRMS
(M+H)+ calculated 458.1962, found 458.1938 for CaftsN iO s.
Benzyl (5S)-5-[(tert-butoxycarbonyl)amino]-4-oxohexanoate (75b)
40%, colorless oil: lH NMR (360 MHz, CDC13) 8 7.39-7.29 (m, 5H), 5.18 (m, 1H), 5.11
59
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(s, 2H), 4.33 (m, 1H), 2.92-2.62 (m, 4H), 1.44 (s, 9H), 1.33 (d, 3 H ,J= 7.1 Hz); l3C NMR
(90 MHz, CDC13) 6 207.9,172.3,155.5,135.7, 128.5, 128.3, 1282 , 79.8,66.5,55.0,
33.6.28.3.27.8, 17.6.

Benzyl (5S)-5-[(tert-butoxycarbonyI)ainino]-4-oxo-5-phenylpentanoate (75c)
60%, colorless oil: lH NMR (360 MHz, CDC13) 8 7.39-7.26 (m, 10H), 5.87 (m, 1H),
5.33 (m, 1H), 5.08 (s, 2H), 2.81-2.50 (m, 4H), 1.41 (s, 9H); l3C NMR (90 MHz, CDCI3) 8
204.2, 172.0, 154.8, 136.8, 135.7,129.2, 128.5, 128.2, 128.1, 127.8,79.9,66.5,64.1,
34.3.28.3.27.9.

Benzyl (5S>5-[(tert-butoxycarbonyl)amino]-4-oxo-6-plienylliexanoate (75d)
55%, colorless oil: 'H NMR (360 MHz, CDCI3) 8 7.39-7.15 (m, 10H), 5.12 (s, 2H), 5.07
(m, 1H), 4.53 (m, 1H), 3.14-3.08 (m, 1H), 2.96-2.90 (m, 1H), 2.84-2.61 (m, 4H), 1.40 (s,
9H); 13C NMR (90 MHz, CDCI3) 8 207.4,172.3, 155.2, 136.2, 135.7, 129.2,128.6,
128.5, 128.2, 126.9,79.9,66.5,60.1,37.4,35.0,28.2,27.8.

Dibenzyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxoheptanedioate (75r)
lH NMR (360 MHz, CDCI3 ) 8 7.38-7.32 (m, 10H), 5.59 (d, 1H, J= 8.5 Hz), 5.11 (s, 4H),
4.50 (m, 1H), 3.00-2.80 (m, 4H), 2.65 (m, 2H), 1.45 (s, 9H); l3C NMR (90 MHz, CDCI3 )
8 206.8, 172.3, 171.6, 155.5, 136.1, 135.5, 128.5, 128.4, 128.2,80.3,66.8,66.5,55.9,
35.6,33.7,28.3,28.0.
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Benzyl (5S)-5,9-bi3[(tert-butoxycarbonyI)ainino]-4-oxononanoate (75t)
69% colorless oil: lH NMR (360 MHz, CDCI3 ) 8 7.39-7.32 (m, 5H), 5.24 (d, 1H, J= 2 2
Hz), 5.11 (s, 2H), 4.68 (bs, 1H), 4.29 (m, 1H), 3.11 (m, 2H), 2.92-2.61 (m, 4H), 1.60-1.26
(m, 6 H), 1.44 (s, 18H); l3C NMR (90 MHz, CDCI3 ) 8 207.8, 172.4,156.2, 155.6, 135.8,
128.5, 128.4, 128.2, 80.0,79.2,66.5,59.0,39.8,34.2, 31.0,29.6,28.4,28.3,27.7,22.0.

(5S)-5-[(tert-butoxycarbonyl)amiiio]-4-oxohexanoic acid (77b)
Refer to preparation o f 78. 98%, white solid: lH NMR (360 MHz, CDCI3) 8 5.28 (bs,
1H), 4.33 (m, 1H), 2.86-2.59 (m, 4H), 1.42 (s, 9H), 1.33 (d, 3H, J =

6 .8

Hz); l3C NMR

(90 MHz, CDCI3 ) 8 208.0, 177.6,155.3,79.9,54.9, 32.4,28.2,27.6,17.5.

N-((l SH-carbomethoxy-2-phenylethyl) (5S)-5-(carboxy-t-butyl)-aniino-4-oxohexanoamide (78)
Into a 10 mL round-bottomed flask containing 90 mg (0.26 mmol) 75b dissolved in 4 mL
absolute EtOH was added 30 mg o f 10% Pd(C). The reaction vessel was stoppered and
thoroughly flushed with nitrogen, charged with hydrogen, and stirred under a balloon of
hydrogen for 10 min. After checking by TLC to ensure starting material was consumed,
the reaction was filtered through a 0.45 uM syringe filter and concentrated to give 65 mg
(99%) o f a white crystalline solid 77 which was dissolved in 4 mL anhydrous DMF. To
this solution was added 53 mg (0.27 mmol) l-(3-dimethylaminopropyl)-3ethylcarbodiimide hydrochloride (EDC), 37 mg (0.27 mmol) l-hydroxybenzotriazole
hydrate (HOBt), 60 mg (0.27 mmol) L-phenylalanine methyl ester hydrochloride, and 37
uL (0.27 mmol) triethylamine. The reaction was stirred overnight, after which 10 mL sat
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aq. NH4 CI solution was added and the reaction mixture extracted with 2 x 20 mL EtOAc.
The combined organic portions were washed with IS mL sa t NaHCOs and 2 x 15 mL
H2 O, dried with MgS0 4 , and concentrated under reduced pressure. Flash
chromatography on silica using 40% EtOAc in hexanes yielded 99 mg (89 %) N-((1S)-1carbomethoxy-2 -phenylethy1) (5S)-5-(carboxy-t-butyl)-amino-4-oxo-hexanoamide 78 as a
white solid; mp = 89 - 90 °C; !H NMR (360 MHz, CDCI3) 8 7.31-721 (m, 3H), 7.117.09 (m, 2H), 6.12 (d, 1H, J = 6.4 Hz), 5.25 (m 1H), 4.83 (m, 1H), 4.29 (m, 1H), 3.70 (s,
3H), 3.14-3.00 (m, 2H), 2.91-2.71 (m, 2H), 2.50-2.41 (m, 2H), 1.43 (s, 9H), 1.32 (d, 3H,

J= 7.16 Hz); 13C NMR (90 MHz, CDCI3) 8 208.5,171.9,171.0, 155.0,135.8, 129.2,
128.5,127.1, 79.9, 55.0,53.1,52.2, 37.8,33.8,29.4,28.3,17.6. HRMS (M +Naf
calculated 429.1996, found 429. 2010 for CziHso^OfiNa.

Benzyl (4S)-4-tert-butoxycarbonyl-5-cyano-3-oxo-pentanoate (80)
10%, colorless oil: 'H NMR (360 MHz, CDCI3 ) 8 7.45-7.38 (m, 5H), 5.38 (d, 1H, 7 = 8.0
Hz), 5.19 (s, 2 H), 4.45 (dt, 1H, J = 7.8, 8.0 Hz), 3.68 (d, 1H, 7 = 16.0 Hz), 3.61 (d, 1H, J
= 15.8 Hz), 2.94 (dd, IH, / = 5.2,17.1 Hz), 2.87 (dd, l H , / = 5.0,17.0 Hz), 1.45 (s, 9H );
13C NMR (90 MHz, CDCI3 ) 8 198.9,171.3,166.5,155.0,134.8, 128.7,128.6, 128.5,
81.8,67.5,55.9,45.3,28.1,19.2.

Benzyl N~2~(tert-butoxycarbonyl)-L-asparaginyl-L-alaninate (81)
In a 25 mL round bottomed flask was added 300 mg (1.29 mmol) L-48n and HOBt (174
mg, 1.29 mmol) to a solution o f H-(L)-Ala-OBn' HC1 (214 mg, 0.99 mmol) in 4 mL
CH2 CI2 containing Et3N (181 uL, 1.29 mmol). After a few minutes, the reaction becomes
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heterogenous and a solution o f D C C (266 mg, 1.29 mmol) in 2 mL CH2 CI2 was added.
The reaction was stirred at room temperature overnight, cooled in an ice bath, and
filtered. The filtrate was diluted with 10 mL EtOAc and washed with 10% citric acid, sat
NaHCCb, and water before drying with MgS0 4 and concentrating. The solid crude
product is vigorously stirred in 10 mL Et20 for lh and the solid filtered to give 381 mg
(75%) pure benzyl N~2~-(tert-butoxycarbonyl)-L-asparaginyl-L-alaninate 81 as a white
solid; mp = 140 -141 °C; *H NMR (360 MHz, C D C b ) 6 7.46-7.32 (m, 5H), 6.15-5.90
(m, 2H), 5.40 (m, 1H), 5.20 (m, 2H), 4.62-4.45 (m, 2H), 2.90-2.85 (m, 1H), 2.60-2.53 (m,
IH), 1.46 (s, 9H), 1.42 (d, 3H, J = 7.3 Hz); l3C NMR (90 MHz, CDCI3) 8 173.5,172.4,
171.0, 155.7,135.3, 128.6,128.4, 128.1,80.3,67.1,50.8,48.3,37.0,28.3,17.9.

N~2~(tert-butoxycarbonyI)-L-asparaginyI-L-alanine (82)
Into a 25 mL round bottomed flask was weighed 200 mg (0.50 mmol) benzyl N~2~-(tertbutoxycarbonyl)-L-asparaginyl-L-alaninate 81 and the flask charged with 10 mL absolute
ethanol and 5 mL glacial acetic acid. Palladium on activated carbon
(10 wt%, 30 mg) was added and the flask placed under a hydrogen atmosphere with a
balloon for 15 minutes. After flushing the flask with nitrogen, the reaction mixture was
filtered through a 0.45 uM syringe filter and concentrated to give 153 mg (99%) of
N~2—(tert-butoxycarbonyl)-L-asparaginyl-L-alanine 82 as a white solid; mp = 203 - 204
°C 'H NMR (360 MHz, CD3OD) 8 4.45-4.34 (m, 2H), 2.69-2.53 (m, 2H), 1.43 (s, 9H),
1.39 (d, 3H, J = 7.2 Hz); I3C NMR (90 MHz, CD3OD) 8 175.7, 175.0, 173.8, 80.8,52.7,
48.2,38.3,28.6, 17.8.

63

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Benzyl (4S)-4-{[N~2~(tert-butoxycarbonyl)-L-asparaginyl]amino}-3-oxopentanoate
(83)
Into a 10 mL round-bottomed flask was weighed 148 mg (0.48 mmol) N~2—(tertbutoxycarbonyl)-L-asparaginyl-L-alanine 82 and the solid dissolved in 2 mL anhydrous
DMF. Carbonyl diimidazole (CDI) 80 mg (0.48 mmol) was added and the solution
stirred until gas evolution ceased (approximately IS minutes). In a separate 25 mL
round-bottom flask which contained a solution of monobenzyl malonate (284 mg, 1.44
mmol) in 10 mL of anhydrous THF was added 284 uL (0.72 mmol) o f a 1M hexane
solution o f dibutylmagnesium at 0 °C. The clear, colorless solution was allowed to warm
to room temperature. The acyl imidazole solution was transferred to the flask which
contained the magnesium salt and the reaction was monitored by TLC. The solution was
allowed to stir for 8 hours and quenched by the addition of 20 mL sat. aq. NH4 CI
solution. The solution was extracted three times with 20 mL EtOAc. The combined
organics were washed with sat. NaHCOj, water, and brine before being dried with MgS0 4
and concentrated. The colorless oil was placed on a high vacuum for 2h and then
crystallization of the material was induced by the addition of a small amount of THF.
The crystalline material was pumped dry to yield 172 mg (81%) o f benzyl (4S)-4{[N~2—(tert-butoxycarbonyl)-L-asparaginyl]amino}-3-oxopentanoate 83 as a white
solid; mp = 173 -1 7 5 (decomp.) °C lH NMR (360 MHz, DMSO-D6) 8 8.30 (m, 1H),
7.40-7.30 (m, 5H), 7.26 (m, 1H), 6.93-6.90 (m, 2H), 5.10 (s, 2H), 4.26-4.20 (m, 2H), 3.65
(s, 2H), 2.43-2.32 (m, 2H), 1.35 (s, 9H), 1.17 (d, 3H, J = 6.9 Hz); l3C NMR (90 MHz,
DMSO-D6 ) 8 203.2,171.7,171.4,167.2,155.2,135.8,128.4,128.0,127.9,78.2,65.9,
54.1,51.2,45.1,36.9,28.1, 15.3.
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Benzyl (5S)-5-{[N~2—(tert-butoxycarbonyI)-L-asparaginyl]ainino}-4-oxohexanoate
(84)
A 25 mL round-bottomed flask was charged with 12 mL anhydrous CH2 CI2 and 150 uL
(1.82 mmol) o f methylene iodide added. The solution was cooled to 0 °C and 1.20 mL
(1.20 mmol) o f a IM solution o f diethylzinc in hexanes was added slowly. The ice bath
was removed and a white precipitate formed rapidly. After stirring for two minutes, 106
mg (0.24 mmol) of solid benzyl (4S)-4- {[N~2~-(tert-butoxycarbonyl)-Lasparaginyljamino}-3 -oxopentanoate 83 was added in one portion and the reaction stirred
2 minutes. The reaction was diluted with 20 mL CH 2CI2 and quenched with 25 mL sat.
aq. NH4 CI solution. The organic portion was dried with MgS0 4 , filtered, and evaporated
under reduced pressure. Column chromatography on silica using

10

% MeOH/CTfcCh

yielded 70 mg (64%) benzyl (5S)-5- {[N~2—(tert-butoxycarbonyl)-L-asparaginyl]amino} 4-oxohexanoate 84 as a colorless oil; 'H NMR (360 MHz, CDCI3) 8 7.38-7.28 (m, 5H),
6.11 (m, 1H), 5.74 (m, 1H), 5.10 (s, 2H), 4.54-4.49 (m, 2H), 2.91-2.55 (m, 6 H), 1.45 (s,
9H), 1.34 (d, 3 H ,y = 7.2 Hz); ,3C NMR (90 MHz, CDCI3) 8 207.1, 173.4, 172.3,171.1,
155.7,135.7, 128.5,128.3,128.2,80.3,66.5,54.2,51.0,36.9,33.6,28.3,27.7,16.9.

(5S)-5-{[N~2—(tert-butoxycarbonyI)-L-asparaginyl]amino}-4-oxohexanoic acid (85)
Into a 10 mL round bottomed flask was weighed 70 mg (0.15 mmol) benzyl (5S>5{[N~2—(tert-butoxycarbonyl)-L-asparaginyl] amino}-4-oxohexanoate 84 and the flask
charged with 3 mL absolute ethanol and I mL glacial acetic acid. Palladium on activated
carbon ( 1 0 wt%,

10

mg) was added and the flask placed under a hydrogen atmosphere

with a balloon for 15 minutes. After flushing the flask with nitrogen, the reaction mixture
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was filtered through a 0.45 uM syringe filter and concentrated to give 55 mg (99%) of
(5S)-5-{[N~2~-(tert-butoxycarbonyl)-L-asparaginyl]amino}-4-oxohexanoic acid 85 as a
white solid; *H NMR (360 MHz, CD3 OD) 8 4.42 (m, 2H), 2.85-2.52 (m, 6 H), 1.43 (s,
9H), 1.32 (d, 3H, J = 7.0 Hz); l3C NMR (90 MHz, CD3 OD) 8 209.3, 176.4,175.0,173.8,
157.7,81.6,55.6,53.0,38.1,34.6,28.6 (2), 16.4.

Benzyl N-((5S)-5-{[N~2—(tert-butoxycarbonyl)-L-asparaginyl]amino}-4oxohexanoyI)-L-ahuiinate (86)
Into a 10 mL round-bottomed flask containing 14 mg (0.09 mmol) L-alanine methyl ester
hydrochloride and 18 uL (0.12 mmol) triethylamine in 5 mL CH2 CI2 was added 46 mg
(0.12 mmol) (5S)-5-{[N~2~-(teit-butoxycarbonyl)-L-asparaginyl]amino}-4-oxohexanoic
acid 85 and 18 mg (0.12 mmol) hydroxybenzotriazole hydrate. The mixture was stirred
10 minutes and 27 mg (0.12 mmol) dicyclohexylcarbodiimide was added before stirring
the reaction overnight The reaction was cooled to 0 °C and filtered through a 0.45 uM
syringe filter before diluting with 10 mL CH2 CI2 and washing with 10 mL sat. citric acid,
10 mL sat. NaHC0 3 and 10 mL H 2 O. The organic portion was dried with MgS(> 4 and
concentrated before chromatographing on silica using 10% MeOH/ CH 2 CI2 to yield 35
mg (60%) benzyl N-((5 S)-5-{[N~2~-(tert-butoxycarbonyl)-L-asparaginyl]amino}-4oxohexanoyl)-L-alaninate 8 6 as a white solid; mp = 195 -198 °C 'H NMR (360 MHz,
CDCVCD 3 OD) 6 8.09 (m, 2H), 6.56 (m, 1H), 4.46-4.38 (m, 3H), 3.73 (s, 3H), 2.92-2.73
(m, 2H), 2.67 (d, 2H, J = 5.8 Hz), 2.59-2.47 (m, 2H), 1.46 (s, 9H), 1.39 (d, 3H, J= 7.3
Hz), 1.36 (d, 3H, J = 7.2 Hz); I3C NMR (90 MHz, CDClj/CDjOD) 8 207.7,173.1,172.2,
171.4, 155.4, 79.4,53.7,51.3,50.7,47.7,36.4,33.0,28.2,27.2, 16.1, 15.1.
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General Procedures for rhgmfatrv on Solid Supports

The chemistry was conducted on a Wang Resin available from Aldrich of a loading (that
is, the amount o f active sites available on the resin when it is swelled in the appropriate
nonpolar solvent prior to reaction) indicated on the label as being “0.5-1.0 mmol/g”, but
found in practice to be a maximum o f 0.6 mmol/g. Following the workup of each
reaction, the beads were thoroughly rinsed with solvent. The beads were dried on the frit
of the reaction tube then placed under a high vacuum overnight. Loading of the resin was
determined by taking 50 mg of dried resin and swelling in 1 mL methylene chloride for 5
minutes. Two ml o f TFA was added and the resin gently stirred with a stirbar for 15
minutes before filtering off the resin, concentrating the solvent, and weighing the
resulting TFA salt. The beads were stored on the lab bench in an ambient atmosphere.
The resin was protected from physical damage by avoiding the grinding of the beads
between hard surfaces and by avoiding repeated cycles of washing with solvents having
different swelling properties (e.g. washing the resin with methanol, then methylene
chloride repeatedly).

p-Nitrophenyloxycarbonyl Resin (87)
A sample o f 1.66 g p-hydroxybenzyloxy alcohol 1% crosslinked polystyrene resin in a 25
mL reaction tube was stirred in 10 mL o f 9:1 CffcCh-pyridine with 0.50 mL of
diisopropylethyl amine and 0.60 g (approximately 3 equiv.) of 4-nitrophenyl
chloroformate was added. After agitation for 24 h the resin was filtered through the frit
of the reactor tube. The beads were washed three times with DMF, three times with
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CH2 CI2 and dried in vacuo overnight to give 1.70 g of orange-brown 4nitrophenyloxycarbonyl resin 87.

Resin-bound (D, L>phenylalanine allyl ester (88)
Into a 10 mL reaction tube was weighed 1.00 g dried p-nitrophenyloxycarbonyl resin and
the resin swelled in 5 mL DMF. To the solution was added 0.675 g (approx. 2 equiv.)
phenylalanine allyl ester p-toluenesulfonate and 0.440 mL (approx. 3 equiv.)
diisopropylethyl amine and the suspension agitated overnight. The resin was washed
three times with DMF, three times with CH2CI2, and dried in vacuo overnight to give
1.30g of 88. Cleavage o f material from the resin by treatment with TFA revealed a
loading of 0.57 mmol/g; lH NMR (360 MHz, CDCI3) 8 7.32-7.16 (m, 5H), 5.78 (tdd, 1H,

J = 6.1,10.5,17.1 Hz), 5.27 (d, 1H, J= 5.8 Hz), 5.23 (s, 1H), 4.56 (d, 2H, J= 5.9 Hz),
4.23 (m, 1H), 3.26 (d, 2H, J= 6.2 Hz).

Resin-bound (D,L)-phenylalanine (89)
Into a 10 mL reaction tube was weighed 1.10 g o f 77 and the vessel charged with 5 mL
dry THF. To the solution was added 1 mL morpholine and 80 mg tetrakis
(triphenylphosphine) palladium (0) and the reaction agitated for 3 h. The resin was
filtered, washed 3 times with THF, three times with DMF, and three times with CH2 CI2 .
The resin was sucked dry through a frit before drying in vacuo overnight to yield 0.92 g
89. The loading was determined to be 0.53 mmol/g after TFA cleavage; ’H N M R of
TFA salt (360 MHz, CD3OD) 8 7.38 (m, 5H), 4.23 (m, 1H), 3.28-3.18 (m, 2H).
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Resin-bound benzyl (D,L)-5-(amino)-4-oxo-6-plienylhexanoate (90)
Into a 5 mL reaction tube containing 106 mg of 89 was added 3 mL THF and the resin
allowed to swell IS minutes and drained. After resuspending the resin in 1 mL THF, 150
mg carbonyldiimidazole was added and the vessel agitated 1.5 h. The THF was drained
and the resin washed with three 2 mL portions of THF before suspending the swelled
resin in 1 mL THF. To the solution was added a solution of 189 mg monobenzyl
malonate in 3 mL THF to which 486 uL dibutylmagnesium was added at 0 °C. The
reaction tube was agitated 8 h before the THF was drained off and the resin rinsed with 2
X 4 mL THF, 2 X 3 mL 5% AcOH in THF, 2 X 3 mL 50/50 THF/H20 , 2 X 3 mL THF,
and 2 X 3 mL CH2 CI2 . The resin was sucked dry on the frit before drying in vacuo
overnight to give 190 mg o f 90 as the dried resin. The loading was determined to be 0.46
mmol/g after TFA cleavage; *H NMR (360 MHz, CDCI3) 6 7.37-7.15 (m, 5H), 5.11 (s,
2H), 4.68 (bs, 1H), 3.51 (bs, 2H), 3.22-3.06 (m, 2H).
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APPENDIX: NMR SPECTRA
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